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To my family 
 
 
 
 
 
The Oyster 
                  There once was an oyster 
                  Whose story I tell, 
                  Who found that some sand 
                  Had got into his shell. 
                  It was only a grain, 
                  But it gave him great pain. 
                  For oysters have feelings 
                  Although they're so plain.  
                  Now, did he berate 
                  The harsh workings of fate 
                  That had brought him 
                  To such a deplorable state? 
                  Did he curse at the government, 
                  Cry for election, 
                  And claim that the sea should 
                  Have given him protection?  
                  No---he said to himself 
                  As he lay on a shell, 
                  Since I cannot remove it, 
                  I shall try to improve it. 
                  Now the years have rolled around, 
                  As the years always do, 
                  And he came to his ultimate 
                  Destiny---stew.  
                  And the small grain of sand 
                  That had bothered him so 
                  Was a beautiful pearl 
                  All richly aglow. 
                  Now the tale has a moral; 
                  For isn't it grand 
                  What an oyster can do 
                  With a morsel of sand?  
                  What couldn't we do 
                  If we'd only begin 
                  With some of the things 
                  That get under our skin. 
                  Anonymous 
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FOREWORD 
The eastern oyster Crassostrea virginica (Gmelin 1791) provides an important 
commercial fishery along the Atlantic and Gulf coast of the United States, and for more than a 
century has been an important part of the local economy and cultural heritage of the state of 
Louisiana. Despite large annual landings, disease problems, environmental fluctuations, and 
reduced summer meat yields, have caused steady declines in production of oysters during the 
past decade. These declines have generated an interest for the production of oysters with 
enhanced growth and disease-resistant characteristics.  
The production of polyploid oysters addresses some of these problems. Triploid oysters 
have an increased growth rate and higher meat yield as a result of decreased fecundity because 
energy reserves go to the production of meat rather than producing gonad. The lack of a reliable, 
consistent, and safe method for the induction of triploidy in eastern oysters has been a major 
obstacle for the production of triploid oysters on a commercial scale. In the Pacific oyster, 
Crassostrea gigas, the production of triploid oysters has been performed successfully by 
crossing diploid with tetraploid oysters. In the eastern oyster, this technique has not yet been 
successful because of the lack of tetraploid broodstocks. Tetraploidy in oysters has only been 
obtained by the chromosomal manipulation of mature oocytes from triploid oysters. The reduced 
fecundity of triploid eastern oysters has been a constraint for the production of tetraploid oysters. 
 The goal of this study was to evaluate the induction of ovarian maturation of triploid and 
diploid eastern oysters by using of the hormone, estradiol-17β, to produce viable oocytes to use 
in the production of tetraploid broodstocks. It has been demonstrated in several species of 
vertebrates and invertebrates that estradiol functions as an oocyte maturation hormone by 
stimulating the synthesis of vitellogenin.    
 v
This thesis is composed of five chapters that are organized in the following order. In the 
first chapter a description of general and reproductive biology of the eastern oyster Crassostrea 
virginica is provided, as well as a short history of the research done on invertebrate 
endocrinology, and the use of estrogens to enhance gonadal maturation in bivalves. It also states 
the general goal and objectives of the thesis. The second chapter describes a new technique to 
quantify gonadal development in histological slides based on image analysis of gonad-to-body 
ratio (GBR) and compares it to existing techniques. This new technique provides a fast and 
comparable estimate of gonadal quantity in oysters. The third chapter provides a qualitative 
description of the gonadal development in triploid oysters that allows categorization of the 
different gonadal stages. The fourth chapter, the core of the thesis, evaluates the effect of 
estradiol-17β on the gonadal development of triploid and diploid female eastern oysters. Finally, 
the fifth chapter provides a summary and general conclusion of the findings of this work, and 
suggests possible uses and applications in the aquaculture industry.     
 The results of his thesis have thus far yielded five published abstracts in conference 
proceedings, These conference presentations include: 1) Effect of the steroid Estradiol-17β on 
the gonadal maturation of diploid and triploid eastern oysters, 2003 Gulf Coast Reproductive 
Biology meeting, New Orleans, Louisiana; 2) Effect of Estradiol-17β on the gonadal maturation 
of the Eastern oyster Crassostrea virginica, 2004 Louisiana Chapter of the American Fisheries 
Society, Baton Rouge, Louisiana, which he was awarded first place in Best Abstract category 
and third place in Best Presentation category; 3) Steroid induced enhanced ovarian maturation in  
the Gulf coast oyster Crassostrea virginica, 2004 World Aquaculture Society, Honolulu, Hawaii; 
4) Effect of Estradiol-17β on the female gonadal maturation of triploid Eastern oysters, 2005 
Aquaculture America, New Orleans, Louisiana; and 5) Rapid estimation of gonad-to-body ratio 
 vi
in oysters, 2005 Aquaculture America, New Orleans, Louisiana, which he was awarded second 
place in Best Poster category. 
For consistency of presentation all chapters of this thesis have been prepared in the 
format of the Journal of Shellfish Research. It is anticipated that Chapters 2, 3, and 4 will be 
submitted for publication in peer-reviewed journals.  
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ABSTRACT 
Declines in annual oyster landings and problems associated with seasonal reduction of 
oyster meat yields have increased interest for development of techniques to produce oysters with 
enhanced growth characteristics.  Research interest has been focused on developing improved 
lines by induction of polyploidy.  The goal of the present study was to evaluate the enhancement 
of gonadal development of triploid oysters, by the use of the hormone estradiol 17-β (E2) to 
produce viable eggs for the development of tetraploid broodstocks. Previous studies with the 
Pacific oyster, Crassostrea gigas, have shown: (1) the need to use the larger eggs of triploid 
females to accommodate a tetraploid nucleus, and (2) that E2 appears to be responsible for 
ovarian maturation.  
The objective of this research was to compare the effect of three dosages of E2 (0.0, 37.5, 
75.0 ng/g wet weight) on ovarian maturation of diploid and triploid eastern oysters, Crassostrea 
virginica, by measuring: 1) gonad-to-body ratio; 2) oocyte area; 3) levels of E2 in the 
hemolymph; and, 4) by qualitatively staging gonadal development. Experiments were performed 
in August of 2003 and May and August of 2004 for 9, 12, and 15 days. Image analysis of 
histological sections (gonadal condition) and enzyme immunoassays (E2 levels) were used to 
evaluate the effects of steroidal treatments.  
There was no evidence of oysters in spawning condition in any of the control groups of 
the triploid oysters, yet oysters in spawning condition were found in the low and high dose 
treatments in percentages as high as 40%.  For the diploid oysters, the effect of E2 was less 
apparent due to their natural state of fecundity during the summer months. Concentrations of E2 
were measured in diploid and triploid oysters and their levels fluctuated from 13.8 to 29.1 for 
diploids and from 16 to 33.8 for diploids, with respect to the stage of gonadal maturation. 
 xv
The overall response of triploid oysters to E2 suggested that this hormone had a positive 
effect on ovarian maturation. These results can have direct applicability for the development of 
tetraploid broodstocks in the eastern oyster.   
 1
CHAPTER 1 - INTRODUCTION 
The eastern oyster, Crassostrea virginica, is a member of the family Ostracea, class 
Bivalvia in the phylum Mollusca. This genus, together with the genera Saccostrea and Ostrea, 
comprise some of the most commercially important bivalve species in the world (NRC 2004). 
The eastern oyster is an intertidal and subtidal bottom dweller that inhabits estuarine 
and coastal waters of the western Atlantic from the Gulf of St. Lawrence in Canada to the coasts 
of Argentina in South America (Carriker and Gaffney 1996).  Its life cycle is divided in a larval 
planktonic stage ranging from 2 to 3 weeks and a sessile benthic stage. The planktonic stage can 
be subdivided in three major larval stages. After fertilization, a non-feeding “trochophore” larva 
develops. This larval stage last approximately 24h, during which the larvae reaches 50 to 60 µm 
in shell width.  After the trochophore stage, the larvae develop into a “veliger” or “D-stage 
larva”. These larvae possess a shell in the form of two valves with a straight hinge giving the 
larvae the appearance of the capital letter “D”. In this stage, the larvae become planktotrophic 
and can reach 70 to 125 µm in shell width. After 12 to 20 days, the veliger larvae modify their 
morphology, forming an umbo that overhangs from the straight hinge line, and a foot with a 
retractor muscle that allows the larvae to crawl. During this “pediveliger” or “eyed-larva” stage 
the larvae s crawl on surfaces searching for suitable hard substrate where they settle, cement, and 
metamorphose into a small oyster called “spat”. From the spat stage, the oyster acquires a sessile 
benthic form that is permanent through the rest of its life, typically forming assemblages called 
reefs, bars, or beds that range in size from a few to hundreds of acres (NCR 2003). Adult oysters 
are filter feeders, mainly feeding on phytoplankton and dissolved organic matter. They have a 
high tolerance to wide ranges of temperature, salinity, and turbidity (Shumway 1996), 
characteristics that make them an ideal specie for aquaculture. 
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Reproduction of the eastern oyster is seasonal, and is highly regulated by temperature 
(Loosanoff and Davis 1953). In the Gulf States, the reproductive season usually starts in late 
March to early April, with the beginning of gametogenesis. Spawning begins to occur in May 
and lasts until late August, but recycling of gonads with subsequent spawning is common as late 
as in October (Supan and Wilson 2001).  
In this thesis, much of the work was based on the evaluation of gonadal development 
and understanding of oogenesis (female gametogenesis). The interplay of oogenesis and gonadal 
development, and how they proceed throughout the reproductive season is important to the 
understanding of this thesis. 
Oogenesis refers exclusively to the process of egg maturation. It is a complex process 
in which primordial germ cells differentiate to become oogonia or oogonial cells, and later 
oocytes and eggs (Figure 1.1). These oogonial cells, besides forming a female gamete or haploid 
cell (cells with one set of chromosomes), also store cytoplasmic enzymes, messenger RNAs, 
organelles, and metabolic substrates that allow gametes to maintain metabolism and 
development. In oysters, oogonia are self-renewing stem cells that endure throughout the 
lifetime. 
Gonadal development is a broader term that describes the changes that occur in the gonad 
throughout the inactive and active reproductive periods.  The gonad is a tissue situated in the 
visceral mass between the digestive gland and the mantle, and in most eastern oysters, primordial 
gonadal tissues develop 8 to 12 weeks after settlement of the spat (Eble and Scro 1996). 
Gonadal development can be divided in stages that include undifferentiated and sexually 
active stages (Figure 1.2). During the undifferentiated stage, the follicles, which are the 
primordial gonadal tissue, are small and separated, and oogonial cells cannot be distinguished 
 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Diagram of the general progression that occurs during oogenesis 
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during this period. When sexual differentiation begins, the ovarian follicles enlarge and invade 
the surrounding vesicular connective tissue. At this point, the oogonia begin to divide rapidly and 
start to differentiate into primary oocytes, the nucleus enlarges and the volume of the primary 
oocytes increases as a result of nutrient accumulation (vitellogenesis). Before spawning occurs, 
the oocytes detach from the germinal epithelia and enter the lumen; these oocytes are 
approximately 40 μm in diameter. After the conclusion of spawning, the follicles shrink and 
surrounding connective tissues begins to grow, the gametes that remain in the follicles are 
eventually  reabsorbed by hemocytes. After this process, the gonad becomes undifferentiated 
again and a new process of gonadal development begins when the appropriate biological and 
physical conditions occur again.  
During the reproductive season, oysters expend most of their stored energy reserves, 
mainly glycogen, for the production, maturation, and spawning of gametes, a process that 
generates a reduction of as much as two-thirds of their body weight (Allen and Dowing 1986). 
This prolonged reproductive season causes reduction of meat yields during the summer months 
and has been a constant and costly constraint for oyster processors in the Gulf States (Supan 
2000). The idea of developing triploid oysters came almost 25 years ago (Stanley and Allen 
1981) as a response to address this problem and to provide profitable meat yields year round. 
Triploidy is a condition where each cell contains three sets of chromosomes instead of 
the usual two sets of most animal somatic cells. This condition results in partial sterility as a 
result of an unbalanced chromosomal state causing irregularities during the meiotic divisions 
(Thorgard 1983). Triploid oysters are a valuable asset to aquaculture because they can retain 
most of their glycogen reserves during the reproductive months, and therefore, meat yields do 
not decrease during this period.  
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Figure 1.2 Photomicrographs of histological sections of the eastern oyster, Crassostrea 
virginica, showing different stages of gonadal development throughout the 2003 reproductive 
season at Grand Isle, Louisiana. This classification is based on the work of Kennedy and Krantz 
1982. 
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 Triploidy in oysters can be induced by several chemical and physical methods, but 
cytochalasin-B (CB) has been used most often because it has been proven to be more effective 
than other methods (Dowing and Allen 1987). Unfortunately, the use CB has several 
disadvantages including: 1) an induction success of less than 80%, 2) highly toxicity that poses 
risks for the untrained personal, and 3) larval mortality rates that are usually higher than normal 
diploid-diploid spawnings. Because of these negative factors, different methods to induce 
triploidy in oysters have been investigated. 
In the Pacific oyster, Crassostrea gigas, triploids are now produced by crossing of 
tetraploid males with diploid females (Guo et al. 1996). This method is used to produce so-called 
“natural triploids” which yields 100% triploid oysters due to the chromosomal combination of 
diploid sperm with a haploid egg, and avoids the negative effects of CB. Another advantage is 
that triploid oysters produced by this method grow faster, 10% in size and 12% in meat weigth, 
than those produced with CB (Wang et al. 2002).  
In oysters, tetraploidy is not a normal condition and several efforts have been explored 
to induce this condition (Guo et al. 1994). So far the only successful method to induce 
tetraploidy is by blocking the first polar body in eggs of triploid oysters fertilized with haploid 
sperm (Guo and Allen 1994). The disadvantage with this method is that it needs sexually mature 
triploid female oysters. Nevertheless, the method has been successful with several oyster species 
(Supan et al. 2000, Eudeline and Allen 2000, He et al. 2000). At the commercial level, triploidy 
production has only been successful in Pacific oysters, because triploid females of this species 
have an ample range of egg production, from 20,000 per individual to 20,000,000 (Guo and 
Allen 1994a). Although the commercial production of triploid oysters began in 1984 (Allen 
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1988), it was not until the development of “natural triploids” that the commercial interest for 
triploid oysters developed in hatcheries around the world (Nell 2002). 
In the eastern oyster, the development of tetraploids has not been as successful as with 
the Pacific oyster. Part of the problem is that sexually mature female triploid oysters in this 
species occur rarely, about 10 in 1,600 (Supan et al. 2000). If successful production of tetraploid 
eastern oysters is to occur, methodologies are needed to induce sexual maturity in triploid 
females, rather than reliance on natural occurrence.  
The reproduction of the eastern oyster, as of most other marine invertebrates, is 
regulated by a combination of exogenous factors (temperature, salinity, food availability) and 
endogenous factors (stored nutrients, endocrine and neuroendocrine compounds) (Giese and 
Pearse 1974). Although numerous experiments have reported the effect of exogenous factors on 
reproduction (Medcof and Needler 1941, Gauthier and Soniat 1989, Paulet and Boucher 1991), 
the study of endogenous factors, such as the function and occurrence of hormones, has been 
limited (Thompson et al. 1996). 
Hormones are substances secreted and transported to other parts of that body to evoke 
physiological responses (Joosse and Geraerts 1983). In vertebrates the occurrence and action of 
hormones on sexual development has been extensively studied since the first experiments of 
Berthold in 1849, where he recorded the effects of castration on the development of secondary 
sexual characteristics in cockerels (Hadley 1992). In invertebrates, endocrinology has been 
biased toward the study of insects and crustaceans, due to the economic importance that they 
represent to agriculture and aquaculture (Tombes 1970). In mollusks, study of the function and 
occurrence of hormones, with the exception of gastropods and cephalopods, has been limited 
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(Joose and Geraerts 1983), but the economic importance of several species of bivalves has 
caused an increased interest of the study of endocrinology. 
Hormones can be categorized into different groups depending on their chemical 
structure, the place in the body where they are produced, and on the physiological effect they 
cause. Among these groups, steroids are a group of hormones that play an important role in 
reproduction. Steroids are organic compounds of adrenal or gonadal origin which share in 
common a basic structure of four carbon rings (Norris 1980). The most commonly occurring 
steroids in vertebrates are the corticoids, progestogens, androgens, and estrogens (Hadley 1992). 
Their common names and functions are giving in Table 1.1. In this thesis, interest will be 
focused on estrogens due to their role in female reproduction development. 
 
 
 
 
 
Category Commonly occurring 
steroids 
Function 
Corticoids Cortisol 
Corticosterone 
Cortison 
 
Carbohydrate metabolism 
Progestogens Pregnenolone 
progesterone 
Maintenance of pregnancy 
Induction of sexual receptivity 
 
Androgens Testosterone 
Androstenedione 
Dehydroepiandrosterone 
Stimulate development of 
male characteristics  
(Masculinizing agents) 
Estrogens Estradiol-17β 
Estrone 
Estriol 
Stimulate development of 
female characteristics 
(Feminizing agents) 
Table 1.1 Common vertebrate hormones and functions 
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Estrogens are a group of hormones synthesized by the reproductive organs and 
adrenal glands in females and in lesser quantities in males. In most vertebrates, estrogens are 
responsible for reproductive processes, such as gonadal differentiation, maturation, and 
oogenesis; and in mammals they are also responsible for secondary sexual characteristics. The 
principal estrogens found in females are estradiol, estrone, and estriol. From these, estradiol-17β 
(E2) is the major estrogen produced by the ovary in vertebrates and is responsible for oocyte 
maturation and development of secondary sexual characteristics (Sadlier 1974). In invertebrates, 
it has been suggested that its main function is the regulation of vitellogenesis (Couch et al. 
1987). 
  Studies on the endocrine control of reproduction in crustaceans have found that some 
groups have the ability to synthesize vertebrate-type steroids such as progesterone and E2, and 
that levels fluctuate closely in accordance with the condition of the ovaries (Pavlof and Goy 
1990, Subramoniam 1999). In bivalves, E2 is believed to be directly involved in the regulation of 
yolk protein formation (Matsumoto et al. 1997). In the Pacific oyster and the Japanese scallop, 
Patinopecten yessoensis, presence of estrogens such as estrone, E2, and estriol has been 
demonstrated (Matsumoto et al. 1997). Although the mechanism of action is not well 
understood, there is evidence that shows that these hormones are linked to the reproductive cycle 
and play an important role in gametogenesis (De Longcamp et al. 1974). For example, levels of 
E2 increase significantly in the hepatopancreas of the red mud crab, Scylla serrata, at the onset of 
vitellogenesis (Warrier et al. 2001). In cultured ovarian pieces of the starfish Asterina 
pectinifera, the oocyte diameter increased significantly when the tissues were incubated with E2 
(Takahashi and Kanatani 1981). In the giant tiger shrimp, Penaeus monodon, the highest levels 
of E2 were found in maturing ovaries (Quinitio et al. 1994).  This estrogen was found to be 
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capable of accelerating glycogenolysis and of accelerating sexual maturation in female Pacific 
oysters (Mori 1969, 1972), and was also demonstrated to be one of the factors controlling 
vitellogenesis in the ovary of this species (Li et al. 1998). 
Information on the effect and occurrence of E2 in the eastern oyster C. virginica is not 
available, and could be of great value in the sexual maturation of triploid female eastern oysters. 
Experiments in this thesis were designed to evaluate at the effect of exogenous estradiol-17β on 
the ovarian maturation of diploid and triploid eastern oysters, with the purpose of producing 
viable oocytes to use for the production of tetraploid broodstocks. The first objective of this 
thesis was to develop a rapid method to quantitatively estimate gonadal development in oysters 
that was comparable to the existing slower methods. The second objective was to create a 
qualitative scale to stage the gonadal maturation of triploid oysters, and the third objective, was 
to evaluate the effect of E2 on the gonadal development of diploid and triploid eastern oysters.    
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CHAPTER 2 - COMPARISON OF METHODS TO ESTIMATE GONAD-TO-BODY 
RATIO IN OYSTERS 
 
According to the Food and Agricultural Organization, more than 90% of global oyster 
production comes from aquaculture (FAO 2002). Methods to assess gonadal condition of oyster 
broodstocks are important to maintain a dependable supply of larvae for culture.  Although 
histological sectioning is expensive and time consuming, and therefore not a practical tool for 
hatchery evaluation of broodstock (Supan and Wilson 2001), its use is essential in detailed 
studies that evaluate gonadal development.  
Although several methods have been used to quantify gonadal condition in oysters, it is 
commonly performed by use of histological transverse sections. Some of these measure only 
gonadal and body widths in predetermined transects (Kennedy and Battle 1964), others 
determine the gonadal and body areas by planimetry (Morales-Alamo and Mann 1989), or by 
techniques based on computer image analysis of specific areas of the gonad (Heffernan and 
Walker 1989). The abundance of different methods and a lack of standardization makes it 
difficult to compare published results, and raises concerns that some of the apparent differences 
in gonadal estimations are due to methodological differences.  
Image analysis has been used to quantify gonadal development in oysters and other 
bivalves in previous studies and its reliability has been demonstrated (Heffernan and Walker 
1989, Buchanan 2001, Delgado and Perez-Camacho 2003). The novelty of the methods tested in 
this chapter is in the use of digital morphometric image analysis based on simple computer 
software. The goal of this work was to identify a fast and reliable method to quantify gonadal 
condition of eastern oysters, Crassostrea virginica, based on a gonad-to-body ratio (GBR) that 
could be comparable to the methods currently employed. The objectives of this study were to: 1) 
compare the GBR obtained by a standard transect method (Supan and Wilson 2001) to three 
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methods that determine gonad and body areas by computer image analysis; 2) compare GBR 
values obtained from the four methods for different gonadal stages; and 3) compare the time 
required for used of each method.  
MATERIALS AND METHODS 
The eastern oysters used in this study were produced at the Sea Grant Grand Isle Bivalve 
Hatchery (29º15’12”N, 90º03’26”W) on Caminada Bay, Louisiana, in June of 2002, and were 
collected in August of 2003, during the spawning season for this species.  The 50 oysters used 
for this experiment were selected randomly from a population held in natural waters, and 
represented the normal stages of gonadal development present during this portion of the 
spawning season (Figure 2.1). 
Figure 2.1 Distribution of gonadal stages for the oysters studied. ED = early development, LD = 
late development, S = spawning, ASR = advanced spawning and regressing (N = 50). 
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Histology 
Sectioning of the oysters for histological comparison was done according to Morales-
Alamo and Mann (1989), (SOP-1). The oyster meats were removed from the shells and a 4-mm 
thick cross-section posterior to the gill-palp junction was dissected, placed in a tissue cassette 
(Omnisette, Fisher-Scientific, Pittsburg, Pennsylvania) and preserved in Davidson’s fixative 
(SOP-2) (Humason 1967). To prepare the samples for histological processing, an automated 
tissue processor (Leica TP1050, Mayer Instruments, Houston, Texas) was used. Tissue samples 
were dehydrated in a stepped alcohol series (70%, 80%, 95%, and 100%), cleared in xylene and 
embedded in paraffin (Paraplast, Tyco/Healthcare Group LP, Mansfield, Massachusetts). By use 
of a microtome (Shandon, Thermo Electron Corp. Pittsburg, Pennsylvania), a 4-µm section 
approximately 1 mm from the gill-palp junction was cut and mounted on a negatively charged 
microscope slide. Each of the slides were placed on a tray inside an autostainer (Leica 
Autostainer XL, Mayer Instruments), where the paraffin was removed and the tissues were 
stained for 30 min with hematoxylin (Anatech Ltd., Battle Creek, Michigan) and counterstained 
for 1 hr with eosin Y (Anatech, Ltd.). Cover slips were mounted above the histological samples 
with permount (Fisher-Scientific, Fair Lawn, New Jersey). 
Transect Method 
The GBR was calculated following a routine methodology (Supan and Wilson 2001) that 
used ten equidistant transects across the section, excluding the mid-dorsal and mid-ventral 
regions of the gonad, and determining the gonadal width relative to the body width on each 
transect (Figure 2.2A). The average GBR value from transects 3 to 8 was used to determine the 
total GBR of each oyster (SOP-3). 
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Image Analysis 
For the three image analysis methods, the same histological section of each oyster used 
for the transect method was digitized on a scanner (Epson Perfection 1640SU, Epson America, 
Inc. Long Beach, California) at a resolution of 300 dpi and imported into Photoshop 7.0 (Adobe 
Inc, San Jose, California). The scanned images were magnified 12 times and analyzed using 
commercially available image analysis software (Metaview 6.1, Universal Imaging Corporation, 
Downingtown, Pennsylvania). The outline of the body following the outer margin of the mantle 
was traced by use of a digital pen and a drawing tablet (Hyper Pen 12000U, Aiptek Inc. Irvine 
California) connected to a personal computer (Dell precision workstation 360, Dell Inc. Austin, 
Texas). The gonad was also traced following the inner and outer margins and avoiding the 
interfollicular space to the extent allowable by the magnification of the digital image (SOP – 4). 
The image analysis software automatically calculated the areas of the body and the gonad by 
counting the number of pixels contained within the traced areas. The first image analysis method 
(no curvature: NC) calculated the GBR by comparing the area of the gonad to the area of the 
body only in a section of the slide comparable to the section used in the transect method, 
excluding the mid-dorsal and mid-ventral regions of the gonad (Figure 2.2B). The second 
method (no gills: NG) calculated the GBR comparing the total area of the gonad to the area of 
the body excluding the gills (Figure 2.2C). The third method (total area: TA) calculated the GBR 
comparing the total area of the gonad to the total area of the body including gills (Figure 2.2D). 
Based on the gametogenic classification described by Kennedy and Krantz (1982) 
(Chapter 1), the oysters were classified into four different groups: early development (ED), late 
development (LD), spawning (S), and advanced spawning and regression (ASR), and the GBR 
values estimated within these groups were compared by the four methods. The time spent 
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performing each method was recorded and compared to determine the effort required for each 
method. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Diagrammatic representation of the four methods used to determine the gonad-to-
body ratio on transects and areas associated with histological sections. Solid lines outline the 
body area; dashed lines outline the gonadal area. 
 
 
Statistical Analysis  
The GBR values obtained with each method were analyzed and compared using the 
Friedman test (Zar 1974), and Dunn’s post-hoc procedure was used to test for differences among 
the four methods. An ANOVA followed by a Tukey’s post-hoc test was performed to test for 
differences among the time required to performed each method. A significance level of α = 0.05 
was used in all statistical analysis. 
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RESULTS 
Determination of the GBR of the oyster cross sections required that the various tissue 
regions be easily distinguishable.  The gonadal tissue was located in a ring shape at the periphery 
of the body mass, but separated from the exterior by the intervening mantle tissue (Figure 2.3). 
The prominent characteristic of the gonad for these studies was the presence of gametes and 
darker basophilic staining of the gonadal tissue. The central region of the sections contained the 
stomach, digestive diverticula, and intestinal branches.  The gill tissue was confined to the 
ventral region of the animal and appeared on only one side of the tissue sections. The “body” 
area included all tissues in the cross sections (as defined by the particular method used) including 
the gonadal tissues.    
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Anatomical features in a transverse histological section of the eastern oyster. AI = 
ascending intestine, DI = descending intestine, DD = digestive diverticula, SC = stomach 
caecum, St = stomach, LG = left gonad, RG = right gonad, M = mantle, and G = gills. 
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There were no significant differences (P > 0.05) among the GBR values derived from two 
of the image analysis methods tested in this work (TA and NC) and the transect method (Table 
2.1). The differences among the GBR values obtained for any oyster by the TA, NC, and TM 
methods were never greater than 10%. The NG method was significantly different (P < 0.05) 
from the other three methods and gave higher estimations of the GBR values 80% of the time. 
These values were always at least 10% higher than the values derived from the other methods. 
 
Table 2.1 Statistical comparison among the different methods to obtain the gonad-to-body ratio 
(GBR) 
*SE: standard error. **Different letters indicate significant differences among treatments, as 
indicated by Dunn’s test (α = 0.05). N=50 
 
 
When the oysters were separated based on their gonadal stages, there were no significant 
differences (P > 0.05) among the four methods when the GBR values were small (≤ 0.10). When 
the GBR values were high (≥ 0.14), there were significant differences among the methods  
(Table 2.2) similar to those observed when the values were pooled for all of the oysters.   
Comparison of the time required to obtain the GBR with each method was significantly 
different (P < 0.05) among the transect method and the three image analysis methods. On 
average, the TA method required 20%, and the NC method 10%, of the time required for the 
transect method (Table 2.3). 
 GBR  
Method Mean ± SE* Comparisons** 
Transect method 0.213 0.011 A 
Total area 0.237 0.013 A 
No gills 0.258 0.013 B 
No curvature 0.214 0.012 A 
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Table 2.2 Statistical comparison among the different methods to obtain the gonad-to-body ratio 
(GBR) at different gonadal stages. 
*SE: standard error. **Different letters indicate significant differences among treatments, as 
indicated by Dunn’s test (α = 0.05). 
 
 
 
 
 GBR  
Method Mean ± SE* Comparisons** 
Early development    
       Transect method 0.082 0.015 A 
       Total area 0.072 0.010 A 
       No gills 0.089 0.007 A 
       No curvature 0.069 0.005 A 
Late development    
       Transect method 0.174 0.022 Abc 
       Total area 0.178 0.016 Ac 
       No gills 0.203 0.014 B 
       No curvature 0.168 0.022 C 
Spawning    
       Transect method 0.251 0.011 A 
       Total area 0.289 0.012 A 
       No gills 0.309 0.013 B 
       No curvature 0.258 0.011 A 
Advanced spawning and regression    
       Transect method 0.148 0.015 A 
       Total area 0.162 0.013 Ab 
       No gills 0.186 0.016 B 
       No curvature 0.158 0.012 Ab 
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Table 2.3 Time comparison among the different methods used to obtain the gonad-to-body 
ratios. 
*SE: standard error. **Different letters indicate significant differences among treatments, as 
indicated by Tukey’s test (α = 0.05).  
 
 
 
DISCUSSION 
The goal of this study was to develop a fast and reliable method to quantitatively estimate 
gonadal condition in oysters based on a gonad-to-body ratio. To achieve this, three methods were 
developed to calculate the area of the gonad and body on histological sections with computer 
image analysis. These methods were compared among themselves and with a reference transect 
method that has been used in several studies to report gonadal condition.  
Of the image analysis methods tested, the TA and NC methods were the fastest and most 
reliable compared to the transect method. Although the TA and NC methods gave results similar 
to the transect method, the NC method was susceptible to visual error at the time of selecting the 
area to be measured, potentially resulting in greater variation when performed by different 
technicians.   
There were no differences among the methods to estimate GBR values when the ratios 
were small, (early development, and advanced spawning and regression). This could be because 
the differences were too small to resolve (< 0.02), but it is important to note that because the 
number of oysters in the ED and ARS stages were small, the statistical power may have been 
 Time (min)  
Method Mean ± SE* Comparisons** 
Transect method 14.7 0.3 A 
Total area   3.1 0.2 B 
No gills   2.7 0.1 B 
No curvature   1.6 0.1 C 
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insufficient to detect differences among the methods.  In this study, this population of oysters 
was chosen because the frequency of stages sampled represented the frequencies observed 
normally during the spawning season. Future studies should address in more detail the 
discriminating power of GBR values across gonadal stages. 
There were several advantages of the computer image analysis methodologies tested in 
this work. They significantly reduced the amount of time required to determine the GBR because 
they were less labor intensive, required only a minimum knowledge of computer software, and 
the GBR values obtained were not different from those of the transect method, allowing direct 
comparison of results among studies.  
Another important difference between the image analysis methods tested in this 
experiment compared to the image analysis methods used in other studies is that these methods 
utilize the complete area of the histological section to estimate the GBR instead of only a few 
fields of the section, which reduces the possibility of erroneous estimation due to sampling error 
or asymmetrical development of the gonad. The use of the total area (TA) method was the most 
successful and therefore is the method recommended because it gives comparable results to other 
existing methods in the literature, is fast (requiring an average of 3 min to complete the GBR of 
one oyster), and once the histological characteristics of the body and gonad have been 
established on the slide, the method is not subject to visual errors by the operator. 
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CHAPTER 3 – GONADAL DESCRIPTION OF FEMALE EASTERN OYSTERS 
The eastern oyster, Crassostrea virginica (Gmelin 1791), provides an important 
commercial fishery along the Atlantic and Gulf coast of the United States, with average annual 
landings of 12.5 metric tons representing $70 millions in dockside value (NMFS 2003). Despite 
large annual landings, there has been a steady decline in production during the past decade due to 
overharvesting, disease, habitat loss, environmental fluctuations, and low summer meat yields 
(Supan 2000). Production declines have generated interest in the production of oysters with 
enhanced growth and disease resistance characteristics (Supan 2000). The production of triploid 
oysters addresses some of these problems. Triploidy refers to the condition of a cell or organism 
having three sets of chromosomes (Guo and Allen 1994). Triploid oysters have an increased 
growth rate during the reproductive season as a result of decreased fecundity because energy 
reserves go to the production of meat rather than in producing gametes.  
Gametogenesis in diploid eastern oysters has been well studied and various 
classifications have been proposed to describe gonadal development (Loosanoff 1942, Kennedy 
and Battle 1964, Kennedy and Krantz 1982). In contrast, only a few studies have been performed 
addressing reproductive development of triploid oysters, and these have been concentrated on the 
Pacific oyster, Crassostrea gigas (Allen et-al 1986, Allen and Downing 1986, 1990). The studies 
specific to the eastern oyster have been conducted in northern latitudes where water temperatures 
are low and spawning seasons are shorter than in the south, factors that could influence gonadal 
condition due to the correlation between water temperature and gonadal maturation (Gauthier 
and Soniat 1989). 
Most of the studies that describe gametogenic development in triploid oysters have been 
focused on evaluating reproductive sterility due to interference of meiosis by the possession of 
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three chromosome sets. It is known that sterility is a common feature of induced triploidy aquatic 
vertebrates (Thorgaard, 1986), but in aquatic invertebrates, especially bivalves, sterility is not 
absolute and the production of mature gametes, although in most cases reduced, is not 
uncommon. In a study done to evaluate gametogenesis in three species of triploid bivalves (M. 
arenaria, C. gigas, C. virginica), retarded gonadal development was reported as the general 
pattern of development for all three species. Nevertheless, the production of oocytes occurred, 
and in some animals in substantial numbers (Allen 1987). Experiments on the reproductive 
potential of triploid Pacific oysters showed that the gametes were capable of fertilization (Guo 
and Allen 1994). This suggests that triploid bivalves have the capability to produce viable 
gametes. 
Estimating gonadal development is important in studies that address reproduction, and 
estimates based solely on quantitative parameters, although important and necessary because 
they provide a quantifiable parameter, do not give enough information on the actual condition or 
the stage of development. A combination of quantitative and qualitative parameters is necessary 
to provide an accurate estimate of the reproductive condition of an organism.     
The goal of this study was to create a descriptive scale of gonadal development for 
triploid female eastern oysters and to estimate the reproductive condition during the spawning 
season based on the quantity and quality of the gonad. The objectives were to: 1) describe and 
classify by stages the gonadal development of diploid and triploid eastern oysters collected 
during August of 2003, and May and August of 2004, 2) estimate gonad quantity based on a 
gonad-to-body ratio, and 3) combine qualitative and quantitative descriptions of gonadal 
development to graphically categorize the potential reproductive condition. 
 
 27
MATERIALS AND METHODS  
Production of Triploids  
The triploid oysters used in this study were produced at the Sea Grant Grand Isle Bivalve 
Hatchery (29º15’12”N, 90º03’26”W) on Caminada Bay, Louisiana in June of 2002, following 
the methodology described by Supan et al. (2000). Eggs from ripe diploid oysters were stripped 
from the gonads and hydrated in 0.45-µm filtered ambient seawater (FSW) for 1 h. The eggs 
were fertilized at a concentration of approximately 10 sperm per egg and monitored until 
appearance of the first polar body in at least 50% of the eggs. A concentration of 0.5 mg of 
cytochalasin B (CB) dissolved in 0.5 ml of dimethyl sulfoxide (DMSO) was added to each liter 
of eggs to induce triploidy. After 10 min, the eggs were rinsed with FSW over a 15-µm screen to 
remove excess sperm, and were soaked in a solution of seawater containing 0.05% of DMSO for 
15 min to wash the CB from the eggs. The eggs were rinsed again with FSW to remove the 
DMSO and were placed in 36,000-L tanks for larval culture. The larvae were set on oyster shell 
cultch (1-8 mm) that was deployed near the shore of Caminada Bay on August 2002 on floats for 
off-bottom culture in ambient water.  
Ploidy Determination 
Flow cytometry was used with all oysters in this study to verify ploidy. From each oyster 
a 0.2-ml hemolymph sample was collected from the adductor muscle sinus by inserting a         
23-ga needle (Becton Dickinson Co. Franklin Lakes, New Jersey) through a notch in the shell. 
The hemolymph was immediately placed into microcentrifuge tubes (Dot scientific Inc. 
Lippincott Burton, Michigan) and placed on ice until analysis, to prevent hemocyte clumping 
(SOP-5).  
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For ploidy analysis, the cells were prepared according to the method of Krishan (1975). 
One hundred microliters of oyster hemolymph were mixed with 35 µl of blood diluted in 
phosphate buffered solution (1 X 106 cell/ml) of male Nile tilapia (Oreochromis nilotica) (SOP-
6) and stained with 1 ml of a solution containing 0.05mg/ml of propidium iodide (Sigma-
Aldrich, St. Louis, Missouri), 38mM sodium citrate (EM Science Inc, Gibbstown, New Jersey), 
0.1% of Triton X-100 (Mallinckrodt Specialty Chemicals Co, Paris, Kentucky) (SOP-7), and 100 
µl of an RNase solution (Sigma Chemicals Co. St. Louis, Missouri) (SOP–8). The samples were 
mixed and filtered through a 35-µm screen and analyzed by flow cytometry after 15 min of 
incubation in the dark. The tilapia blood was used as an internal reference to correct for factors 
that can cause variations in DNA readings. 
Analyses were performed with a FACScalibur flow cytometer (Becton Dickinson, San 
Jose, California) with an air-cooled argon laser at a wavelength of 488 nm. Individual nuclei of 
lysed hemocytes and erythrocytes were analyzed at a rate of 100-200 particles per second   
(SOP-9). The fluorescence of each particle analyzed was transmitted as an analog signal to a 
computer, and the signal was digitized to generate pulse-height histograms that represented a 
minimum of 30,000 cells. Cellquest Software (Becton Dickinson) was used to calculate the 
fractional mode channel (peak channel) of each histogram fluorescence peak. Measurement of 
oyster DNA content was expressed as picograms of DNA per cell in relation to an assigned value 
of 2.00 pg/cell for fresh red blood cells from channel catfish Ictalurus punctatus that was used as 
an external reference (Tiersch et al. 1990). Oyster DNA content was calculated by the formula: 
DNA content = (O/T)(T/C) x  2.0; where O, T, and C, are the fractional mode channels of the 
oyster, tilapia and catfish, and 2.0 is the DNA content value in picograms of the channel catfish. 
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Histology 
Sectioning of the oysters for histological comparisons was done according to       
Morales-Alamo and Mann (1989) (SOP–1). The oyster meats were removed from the shells and 
a 4-mm thick cross-section just posterior to the gill-palp junction was dissected, placed in a 
tissue cassette (Omnisette, Fisher-Scientific, Pittsburg, Pennsylvania) and preserved in 
Davidson’s fixative (Humason 1967) (SOP–2). An automated tissue processor (Leica TP1050, 
Mayer Instruments, Houston, Texas) was used to prepare the samples for histology. Tissue 
samples were dehydrated in a stepped alcohol series (70%, 80%, 95%, and 100%), cleared in 
xylene and embedded in paraffin (Paraplast, Tyco/Healthcare Group LP, Mansfield, 
Massachusetts). With a microtome (Shandon, Thermo Electron Corp. Pittsburg, Pennsylvania) a 
4-µm section approximately 1 mm from the gill-palp junction was cut and mounted on a 
negatively charged microscope slide. Each of the slides was placed on a tray inside an 
autostainer (Leica Autostainer XL, Mayer Instruments), where the paraffin was removed  and the 
tissues were stained for 30 min with hematoxylin (Anatech Ltd., Battle Creek, Michigan) and 
counterstained for 1 hr with eosin Y (Anatech Ltd.). Cover slips were mounted above the 
histological sections with permount (Fisher Scientific, Fair Lawn, New Jersey). 
Quantitative Analysis 
Gonad-to-body ratios were estimated by comparison of gonad and body areas calculated 
by image analysis (Chapter 2) (SOP-4). To do this, the histological sections were digitized on a 
scanner (Epson Perfection 1640SU, Epson America, Inc. Long Beach, California) at a resolution 
of 800 dpi and imported into Photoshop 7.0 (Adobe Inc, San Jose, California). The scanned 
images were magnified 12 times and analyzed using image analysis software (Metaview 6.1, 
Universal Imaging Corporation, Downingtown, Pennsylvania). To calculate the body area, the 
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outline of the body following the outer margin of the mantle and gills was traced by use of a 
digital pen and a drawing tablet (Hyper Pen 12000U, Aiptek Inc, Irvine, California) connected to 
a personal computer (Dell precision workstation 360, Dell Inc, Austin, Texas). The gonad was 
also traced following the inner and outer margins avoiding the interfollicular space to the extent 
allowable by the magnification of the digital image. The image analysis software automatically 
calculated the areas of the body and the gonad by counting the number of pixels contained within 
the traced area.   
Gonadal Description 
Complete gonad sections from each histological slide were microscopically examined to 
describe the gonadal development of each oyster. Classifications used to stage the gonadal 
development included early development, late development, spawning, and spawned (adapted 
from Kennedy and Krantz 1982). For the triploid oysters, the same classification was followed 
with the inclusion of two more stages, defined as indifferent and reduced development.  
Statistical Analysis 
A comparison of GBR values of each stage of gonadal development in each ploidy was 
conducted to test for differences among the stages, using a one-way analysis of variance 
(Statistical Analysis Software system Version 9 for Windows®, SAS Institute Inc., Cary, North 
Carolina). The model included GBR as the dependent variable and stage as the fixed effect. Also, 
comparison of the GBR values of diploid and triploid oysters at the same stage of development 
was performed, to find quantitative differences between the two ploidies. A Tukey-Kramer test 
was used to compare stage differences, and these were considered to be significant at P < 0.05.  
The GBR values met the assumption of normality and homogeneity of variance after square root 
transformation (Kutner et al. 2005). 
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RESULTS 
Gonadal Description 
Diploid Female Oysters 
The gonadal condition of the diploid female samples evaluated during the two summers 
was representative for that time of the year in coastal Louisiana. The gonads of the majority of 
oysters (68%) were found to be in spawning condition, defined as gonads full of non-pendant 
(not connected to the follicle wall) mature oocytes, with a disrupted follicular arrangement or no 
clear division between follicles (Figure 3.1). 
 
 
 
 
 
 
 
 
Figure 3.1 A & B Photomicrographs of a histological section showing a female diploid eastern 
oyster in spawning condition (Stage V). M: mantle; G: gonad; DD: digestive diverticula;         
Oc: oocytes. 
 
 
Triploid Female Oysters 
Gonadal development in the triploid eastern oysters during both summers was retarded 
compared to diploids, but the gonadal condition was able to be categorized into six descriptive 
stages based on the degree of development as defined below: 
G 
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DD 
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Stage I.- Indifferent: In this stage, follicular development was absent or reduced with no 
follicular branching, dominant interfollicular space (connective tissue), and no evidence of 
oogonia or distinguishable sex cells were observed in the follicles (Figure 3.2). 
 
 
 
 
 
 
 
 
Figure 3.2 A & B Photomicrographs of a histological section showing an indifferent gonadal 
condition (Stage I) of a female triploid eastern oyster. M: mantle; CT: connective tissue;            
F: follicles; FC: follicular cells. 
 
 
Stage II.- Reduced Development: Follicular development was arrested with little or no 
follicular branching, and dominant interfollicular space. Few oocytes were present (1 to 20 in the 
whole histological section), but they were mature with a large distinct germinal vesicle. All 
oocytes were inside the follicles and in general did not appear to be pendant to the follicular wall. 
The follicles that had oocytes usually had only one and this was surrounded by undeveloped 
germinal cells. This was the typical gonadal condition for the majority of the triploid oysters 
(Figure 3.3). 
Stage III.- Early Development: In this stage, the gonad presented follicular 
development with some branching and a prominent reduction in the interfollicular space. 
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Oogonia were observable and the oocytes present inside the follicles were still pendant      
(Figure 3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 A & B Photomicrographs of a histological section showing a reduced gonadal 
condition (Stage II) of a female triploid eastern oyster. M: mantle; Oc: oocyte; F: follicles;      
CT: connective tissue; FC: follicular cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 A & B Photomicrographs of a histological section showing an early development 
gonadal condition (Stage III) of a female triploid eastern oyster. M: mantle; CT: connective 
tissue; F: follicles; Oc: oocytes. 
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Stage IV.- Late Development: In this stage, there was an increase in the size and 
number of follicles, significant branching and a reduction of interfollicular space compared to the 
early development stage. Several mature oocytes were observed inside the follicles usually 
projected into the lumen. There were some developing pendant oocytes (Figure 3.5). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 A & B Photomicrographs of a histological section showing a late development 
gonadal condition (Stage IV) of a female triploid eastern oyster. M: mantle; Oc: oocytes; F: 
follicles; CT: connective tissue. 
 
 
Stage V.- Spawning Condition: In this stage, the gonad had follicles full of oocytes with 
prominent clear germinal vesicles in most of them, and almost no interfollicular space, no clear 
division between follicles. The oocytes presented an irregular arrangement and only a few 
developing oocytes were pendant (Figure 3.6) 
Stage VI.- Spawned: Gonads in this stage presented follicular disorganization, extensive 
interfollicular space, and the appearance of connective tissue in the interfollicular areas. 
Numerous mature oocytes were observed free in the lumina and in the genital canals          
(Figure 3.7).   
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Figure 3.6 A & B Photomicrographs of a histological section showing a spawning gonadal 
condition (Stage V) of a female triploid eastern oyster. M: mantle; G: gonad; DD: digestive 
diverticula; CT: connective tissue; Oc: oocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 A & B Photomicrographs of a histological section showing a spawned gonadal 
condition (Stage VI) of a female triploid eastern oyster. M: mantle; F: follicles; CT: connective 
tissue; DD: digestive diverticula; Oc: oocytes. 
 
 
Quantitative Analysis 
In the diploid oysters, only the GBR value of the oysters at Stage III was not significantly 
different (P > 0.05) to the oysters at Stages I and VI, the rest of the stages were significantly 
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different (Table 3.1). In the triploid oysters, only those with a gonadal condition of Stage V had a 
significantly different (P ≤ 0.05) GBR value from the oysters at other gonadal stages (Table 3.2).  
The comparison diploid and triploid GBR values of the same stages showed that only the 
oysters with gonads at Stage IV had a significantly different GBR value (P < 0.05).  
 
 
Table 3.1 Statistical comparison of the gonad-to-body ratio (GBR) by developmental stage in 
diploid eastern oysters (N = 212). 
* LS mean: Least significant mean; **SD: Standard deviation; ***Different letters indicate 
significant differences among developmental stages, as indicated byTukey-Kramer test (α = 
0.05).  
 
 
 
Potential Reproductive State 
The descriptive classification of the diploid and triploid gonad condition with their 
respective GBR values were combined to graphically illustrate the reproductive potential of 
eastern oysters based on the quality and quantity of the gonad (Table 3.3). In general, the GBR 
values of diploid oysters were higher than those of triploid oysters at later stages of development 
(Stages IV, V, and VI), but only the gonads at Stage IV had significantly different (P < 0.05) 
 GBR  
Gonadal stage LS mean* SD** Comparison*** 
Undifferentiated (I) 0.068 0.043 A 
Early development (III) 0.119 0.054 Ad 
Late development (IV) 0.208 0.067 B 
Spawning (V) 0.320 0.073 C 
Spawned (VI) 0.141 0.062 D 
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GBR values. At earlier stages (I and III), the GBR values of triploid oysters were within the 
same range as the diploid oysters. 
 
 
Table 3.2 Statistical comparison of the gonad-to-body ratio (GBR) by developmental stage in 
triploid eastern oysters (N =215). 
*LS mean: Least significant mean; **SD: Standard deviation; ***Different letters indicate 
significant differences among developmental stages, as indicated by Tukey-Kramer test (α = 
0.05).  
 
 
DISCUSSION 
Normal summer gonadal condition (Stage V) was mostly found in the diploid eastern 
oysters examined during May and August of 2003 and 2004 for Louisiana waters. In triploid 
eastern oysters, although different degrees of gonadal development were found, the typical 
characteristic was oysters with reduced gametic and gonadal development (Stage II). A similar 
pattern of gonadal development was reported for cultured triploid Pacific oysters (Allen and 
Downing 1990). 
 
 GBR  
Gonadal stage LS Mean* SD** Comparison*** 
Indifferent (I) 0.063 0.033 A 
Reduced development (II) 0.070 0.029 A 
Early development (III) 0.079 0.034 A 
Late development (IV) 0.094 0.046 A 
Spawning (V) 0.257 0.105 B 
Spawned (VI) 0.078 0.042 A 
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Table 3.3 Distribution of gonadal condition by gonad-to-body ratio (GBR) in diploid (blue) and 
triploid (yellow) eastern oysters, and their intersection (green). 
 
 
I II III IV V VI 
0.0-0.05       
0.06-0.10       
0.11-0.15       
0.16-0.20       
0.21-0.25       
0.26-0.30       
0.31-0.35       
0.36-0.40       
0.41-0.45       
0.46-0.50       
0.51-0.55       
 
 
Although a reduced gonadal development (Stage II) was expected for the triploid oysters, 
it is not clear why only a few primary oocytes matured even when the gonad had visible oogonial 
cells and large reserves of glycogen. The theory of chromosomal disruption during meiotic 
divisions does not fully explain the reason for the arrested development of oocytes because 
meiotic divisions begin normally after the oocyte has been fertilized, after vitellogenesis has 
occurred. This suggests that factors that affect the mobilization of energy reserves and nutrients 
GBR 
Stage 
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(vitellins) into gamete must have a larger impact than genetic aberrances on the maturation of 
oocytes. 
Although the gonadal development found in the majority of triploid oysters was reduced 
and in those oysters that developed beyond Stage II, the gonadal material was less abundant 
when compared to diploid oysters, a gradual gonadal development in triploid oysters similar to 
diploids was observed, suggesting that both follow the same path of gonadal development albeit 
at different rates, allowing similar categorization.  
Although the inclusion of a Stage II helped to describe part of the gonadal development 
in triploid oysters and to differentiate between a reduced development and an early developing 
gonad (Stage III), the comparison of these two stages based on GBR values showed no 
significant differences.  In subsequent chapters of this thesis, Stages II and III of the triploid 
oysters were merged into a single stage, (Stage III) to allow comparison with diploid oysters and 
facilitate statistical analysis.  
The fact that some triploid eastern oysters were found in Stage VI with clear signs of 
having spawned, even in cases were the gametes were not mature, was evidence that triploid 
oysters were capable of spawning regardless of the quantity or quality of gonadal material. This 
suggests that the factors that regulate spawning might not be strongly dependent on the state of 
gonadal maturity. 
None of the eggs found in the mature triploid females during these experiments were 
fertilized, but based on the quality of the gonad and the characteristics of the gametes it could 
have been possible that some of these gametes would have been capable of fertilization. In 
triploid Pacific oysters mature eggs have been able to be fertilized and to produce viable larvae 
(Guo and Allen 1994). Thus, based on the gonadal and gametic characteristics of the ovaries of 
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triploid eastern oysters, it can be predicted that oysters with GBR values of 0.2 or higher are 
potentially capable of reproduction.  
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CHAPTER 4 – EFFECT OF ESTRADIOL-17β ON OVARIAN DEVELOPMENT 
OF DIPLOID AND TRIPLOID EASTERN OYSTERS 
 
In vertebrates, estradiol is the major steroid hormone secreted by the ovary. Estradiol 17-
β (E2) is a steroid hormone from the family of estrogens that also includes estrone and estriol, 
and together with estradiol are the most important estrogens found in vertebrates (Sadleir 1974). 
In mammals, estradiol is secreted during the follicular or preovulatory phase of the ovary and 
plays an important role in oocyte and follicle maturation (Hadley 1992). In oviparous vertebrates 
like the chicken, transcriptional activation of the vitellogenin gene in liver cells is estrogen 
dependent (Edinger et al. 1997). In fish, estradiol functions as an oocyte maturation hormone by 
stimulating the synthesis of vitellogenin, a precursor of yolk (Wallace and Selman 1981). In a 
study done with tilapia, Oreochromis mossambicus, to measure the effect of E2 on the synthesis 
of vitellogenins, it was found that the levels of two vitellogenin proteins in the plasma increased 
after the fish were injected with estradiol, indicating the importance of estrogens in the process 
of oocyte maturation (Tekemura and Kim 2001). 
In marine invertebrates, the presence of estrogens in several tissues has also been 
demonstrated and the effect on gonadal development seems to be similar to that in vertebrates 
(Takahashi and Kanatani 1981, Subramoniam 1999, Warrier et al. 2001). Several species of 
decapod crustaceans have shown the ability to synthesize steroid hormones similar to vertebrate 
E2 to stimulate vitellogenesis (Pavlof and Goy 1990). Studies on the tiger shrimp (Penaeus 
monodon), have shown that the levels of estradiol and progesterone in the hemolymph and in 
tissues such as ovary and hepatopancreas correlated positively with progressive stages of ovarian 
maturity (Quinitio et al. 1994). The same pattern was observed for the red mud crab, Scylla 
serrata, where the levels of E2 and progesterone increased sharply in the ovary and 
hepatopancreas at the onset of vitellogenesis (Warrier et al. 2001). 
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In bivalves, the presence of estrogen-like steroids has also been reported. Studies on 
gonadal estrogen profiles done with the Pacific oyster, Crassostrea gigas, and the Japanese 
scallop, Patinopecten yessoensis, identified the presence of estriol, estrone, and E2, with E2 being 
found at higher concentrations in the ovary and increased with sexual maturation (Matsumoto et 
al. 1997). Other studies have also demonstrated that E2 is capable of accelerating sexual 
maturation in female Pacific oysters (Mori 1969). In this same species, E2 treatments in vivo 
causes significant increases in oocyte diameter and vitellin content and appeared to be one of the 
major factors that controlled vitellogenesis (Li et al. 1998). 
In the United States, the oyster industry has traditionally depended on fisheries based on 
public reefs or private lease systems to supply the domestic market. Although private leasing has 
been considered as a form of aquaculture because it involves the manipulation and transportation 
of juvenile oysters to desirable growing areas, it is an extensive form of culture that offers little 
control over the outcome of transported animals. As aquaculture evolves, species with enhanced 
characteristics such as faster growth and disease resistance will be more desirable, especially as 
culture practices are transformed from extensive artisan methodologies to intensive and more 
industrialized practices.  
Production characteristics of traditional concern are growth rates and meat yields. In 
oysters, a drastic reduction of body tissue occurs in summer months in Louisiana coastal waters 
due to the natural spawning cycle. During spring maturation and spawning, glycogen stores are 
depleted as the gametes mature.  The glycogen stores are not fully replenished during the 
summer and meat yields decline accordingly.   
One solution that addresses this natural phenomenon came almost 25 years ago when 
triploid oysters were produced with the purpose of enhancing growth rates and increasing meat 
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yields (Stanley et al. 1981). Triploidy is a genetic condition where the organism has three sets of 
chromosomes (3N) instead of two (2N), which is the normal condition for most animals (Guo 
and Allen 1994). The result of triploidy in oysters is an almost complete reproductive sterility 
due to an abnormal chromosomal paring at the meiotic divisions (Thorgaard 1986). The absence 
of maturing gametes allows energy reserves of the oysters to go to somatic (meat) development 
rather than gonadal growth (reproduction). The option of producing triploid oysters to overcome 
problems of reduced meat yields in the summer has proven to be effective, to the point that on 
the west coast of the United States, 30% of the Pacific oysters grown are triploids (Nell 2002) 
and this percentage is likely to increase with increased demand for more and better quality 
products, especially during the summer months. 
Three methods have been used to induce triploidy in animals: 1) manipulation of the 
environment (physical); 2) addition of chemicals to interfere with meiosis (chemical), and 3) 
mating between diploid and tetraploid animals (natural triploids). In oysters, the most commonly 
used method is the addition of chemicals to newly fertilized eggs to prevent the release of a polar 
body, causing retention of an extra set of chromosomes. This method although simple, has 
notable disadvantages. The chemicals are highly mutagenic, therefore, dangerous to untrained 
personal, the percentage of triploidy is typically less than 80%, and larval mortality rates are 
higher than in diploid-diploid crosses. In 1994, researchers from the Haskin Shellfish Research 
Laboratory at Rutgers University (Guo and Allen 1994a) developed a method to produce 
tetraploid oysters (4N), oysters with four sets of chromosomes, using oocytes from sexually 
mature triploid females. Production of large numbers of tetraploids enabled production of natural 
triploids by crossing tetraploid with diploid oysters, eliminating the use of noxious chemicals, 
increasing success of triploidy production to practically 100%, and reducing larval mortality 
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levels to those of diploid-diploid crosses. This technique, however, is dependent on sexually 
mature triploid females to start tetraploid broodstock lines. In the Pacific oyster, this was not a 
great concern because it is not uncommon to find triploid females with sufficient numbers of 
mature oocytes. However, for the eastern oyster, C. virginica, the concept of producing natural 
triploid oysters did not work well, because it is rare to find triploid females with mature oocytes 
or oocytes in sufficient numbers for producing tetraploids.  
The requirement of sexually mature triploid eastern oysters to develop tetraploid oyster 
broodstocks provided impetus for the idea of enhancing gonadal development by the use of 
steroid hormones. Estradiol-17β is a likely candidate to stimulate oocyte maturation on eastern 
oysters based on the diversity of species that respond to high levels of estrogens during 
gametogenesis. 
The purpose of this study was to evaluate the effect on enhance ovarian maturation of 
triploid eastern oysters by the use of the hormone E2 to produce viable oocytes for use in 
production of tetraploid broodstocks. The objectives were to: 1) compare on quantitative and 
qualitative scales the effect on gonadal development of three dosages of E2 in triploid and diploid 
eastern oysters, and 2) measure the concentration of E2 in hemolymph of diploid and triploid 
oysters from the control groups, to establish its presence and correlate titers with the gonadal 
stage. The results of this study showed a positive correlation between the use of E2 and gonadal 
maturation for female triploid oysters. 
MATERIALS AND METHODS  
The experiments were performed at the Sea Grant Grand Isle Bivalve Hatchery 
(29º15’12”N, 90º03’26”W) on Caminada Bay, Louisiana, in August of 2003, and were repeated 
in May and August of 2004. The diploid and triploid eastern oysters used in these studies were 
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produced and cultured at the Grand Isle Hatchery and were collected 2 weeks prior to each 
experiment.  
Triploid Induction and Verification 
The triploid oysters used in the three experiments were produced by chemical induction 
in June of 2002 following the methodology described by Supan et al. (2000). Briefly, newly 
fertilized eggs were treated with a solution containing 0.5mg of cytochalasin B (CB) dissolved in 
0.5 ml of dimethyl sulfoxide (DMSO) in 1 L of filtered sea water. The CB solution was added 
when 50% of the eggs showed polar body 1 and the duration of the treatment was 10 min. 
The ploidy of each oyster was verified by flow cytometry a week before each experiment, 
and verified again after the experiment in the cases were triploid oysters were found in spawning 
condition. Briefly, the cells were prepared according to the method of Krishan (1975). One 
hundred microliters of oyster hemolymph were mixed with 35 µl of blood of male Nile tilapia 
(Oreochromis nilotica) diluted in phosphate buffered solution (1 X 106 cell/ml) (SOP-6) and 
stained with 1 ml of a solution containing 0.05mg/ml of propidium iodide (Sigma Chemical Co. 
St. Louis, Missouri), 38mM sodium citrate  (EM Science Inc, Gibbstown, New Jersey), 0.1% of 
Triton X-100 (Mallinckrodt Specialty Chemical Co, Paris, Kentucky) (SOP-7), and 100 µl of 
RNase solution (Sigma Chemical) (SOP-8). Oysters tested as diploids were also used in the 
experiment to measure the effect of E2 in female diploids. 
Experimental Design 
A total of three experiments were conducted during the summer of 2003 and 2004. In 
August of 2003 a total of 90 triploid oysters and 60 diploid oysters were used from the same 
cohort. This experiment also included 60 diploid oysters from a different cohort that were never 
exposed to CB for triploidy induction, with the purpose of evaluating differences in response to 
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the estrogen between diploid oysters exposed and not exposed to CB. The oysters from this 
experiment were under treatment for 12 d. In May of 2004 a total of 240 triploid and diploid 
oysters were used from the same cohort. One half of the population of oysters from this 
experiment was under treatment for 9 d and the rest for 12 d. In August of 2004 a total of 360 
triploid and diploid oysters from the same cohort as in the previous experiments were used. One 
half of the population of oysters from this experiment was under treatment for 12 d and the rest 
for 15 d. In all of the experiments a sample of 20 diploid and triploid oysters was evaluated at the 
beginning of the experiment to determine the initial gonadal condition.   
The treatments consisted of: 1) a control with no E2; 2) a low dose with 37.5 ng of E2 per 
g of wet weight; and, 3) a high dose with 75 ng of E2 per g of wet weight. These dosages were 
chosen based on the response of oysters to E2 in preliminary experiments conducted in August 
and September of 2001 (J. Lynn, LSU Department of Biological Sciences, unpublished data). 
The diploid and triploid oysters were divided equally among the treatments. The appropriate E2 
doses were applied every 3 d during the experiment by injection into the adductor muscle 
through a notch in the shell, using a 1-ml tuberculin syringe (Becton Dickinson, Franklin Lakes, 
New Jersey) with a 23-ga needle (Becton Dickinson). After injection, the oysters were held out 
of the water for 30 min to prevent flushing of the E2 solution. Duration and dosage regime of the 
experiments are detailed in Table 5.1. 
Calculation and Preparation of the Estradiol Dosages 
The dosages were estimated on a body wet weight basis. Because there was no direct way 
to measure the body meat weight of an oyster without killing it, a linear regression of shell length 
to body weight was used to estimate the body weight, based on measurements of 750 triploid and 
diploid eastern oysters collected from 1994 to 1997 by Dr. Supan (Figure 5.1).
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Table 4.1 Estradiol-17β dose injection and evaluation schedule for the experiments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Injection and evaluation days 
Experiment Day 0 Day 3 Day 6 Day 9 Day 12 Day 15 
August 2003 1st dose 
 
 
2nd dose 3rd dose 4th dose Final evaluation -------- 
 
 
May 2004 
 
1st dose 
 
2nd dose 
 
3rd dose 
 
4th dose  
and 
1st evaluation 
 
Final evaluation 
 
-------- 
 
 
August 2004 
 
1st dose 
 
2nd dose 
 
3rd dose 
 
4th dose 
 
5th dose  
and 
1st evaluation 
 
Final evaluation 
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The shell height values of triploid and diploid oysters were combined after covariant 
statistical testing showed no significant differences (P > 0.05) in the slope of the regression line 
of diploid and triploid oysters. 
 
 
 
 
 
 
 
 
 
Figure 4.1 Linear regression of shell height by body wet weight from diploid and triploid eastern 
oysters  
  
 
To simplify the application of the dosages, the oysters were divided into 8 shell height 
categories, from 70 mm to 150 mm, in intervals of 10 mm, and the dose for each category was 
calculated using the mean shell length of that category.  
The solution for the control treatment consisted of filtered sea water with a concentration 
of 0.1% DMSO. The solution for the low dose treatment consisted of FSW with a concentration 
of 3125 ng/ml of β-Estradiol 98% (Sigma Chemical), and for the high dose treatment was FSW 
with a concentration of 6250 ng/ml of β-Estradiol (Sigma Chemical) the appropriate volume was 
injected based on the oyster shell height (SOP-10). 
Description of Systems 
The experiments were done in a 500-L rectangular fiberglass tank with continuous flow 
of filtered (100 µm) ambient sea water. The oysters were held in labeled plastic bins within an    
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8 x 5 array (Figure 5.2) to keep them in a known position throughout the experiment. Neither 
temperature nor food was regulated during the experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Experimental units were plastic bins in an 8 x 5 array that separated individual 
oysters. 
 
 
Histology 
Sectioning of the oysters for histological comparisons was done according to       
Morales-Alamo and Mann (1989) (SOP-1). The oyster meats were removed from the shells and a 
4-mm thick cross-section posterior to the gill-palp junction was dissected, placed in a tissue 
cassette (Omnisette, Fisher-Scientific, Pittsburg, Pennsylvania) and preserved in Davidson’s 
fixative (Humason 1967) (SOP-2). Processing of the tissue samples was done on an automated 
tissue processor (Leica TP1050, Mayer Instruments, Houston, Texas). A 4-µm section was cut 
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approximately 1 mm from the gill-palp junction, mounted on a microscope slide, stained with 
hematoxylin (Anatech Ltd, Battle Creek, Michigan) and counterstained with eosin (Anatech). 
Quantitative Analysis (Gonad-to-body ratio) 
Gonad-to-body ratios were estimated from histological samples by comparison of gonad 
and body areas calculated by image analysis (SOP-4).  
Qualitative Analysis (Gonad staging) 
Complete gonad sections from each histological slide were microscopically examined to 
determine the gonadal development of each oyster. The stages used to categorize the gonadal 
development on each oyster were: indifferent (I), reduced development and early development 
(III), late development (IV), spawning (V), and spawned (VI). The description of each stage is 
given in Chapter 3. After determining that there was no statistical difference between the GBR 
values of Stages II and III (as explained in Chapter 3), Stage II was omitted from the gonadal 
classification and the oysters in this stage were reclassified as Stage III. This was done for the 
purpose of adding replication to the group of triploid oysters in Stage III, and to standarized the 
statistical comparison of treatments in the diploid and triploid groups.  
Estradiol Assay 
The levels of E2 in hemolymph samples of all the oysters in the control groups of each 
experiment were measured using a colorimetric estradiol enzyme immunoassay kit (Cayman 
Chemical Company, Ann Arbor Michigan) which was based on the competition between free 
estradiol (sample) and a known concentration of estradiol (constant) for a limited number of 
specific binding sites for each well of a 96-well assay plate. A 1-ml hemolymph sample was 
drawn from the adductor muscle using a 1-ml syringe (Becton Dickson) with a 23-ga needle 
(Becton Dickinson). The sample was transferred to a 1.5-ml cryogenic vial (Cryoware Nalge 
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Nunc Int. Corp., Rochester, New York) and immediately frozen in liquid nitrogen (SOP-5). The 
samples were stored at -800C until analysis. 
Oocyte Area 
The area of 50 randomly chosen oocytes from histological slides of diploid and triploid 
eastern oysters at Stage V were measured by image analysis (SOP-11). Comparison of the total 
oocyte mean area of each treatment was done to test for differences among treatments. Only 
gonads of oysters at Stage V were evaluated to ensure the same level of development. Only 
oocytes with a clear germinal vesicle and nucleolus were selected for measurement. 
Statistical Analysis 
Comparisons of the total GBR values of each treatment were conducted to test for 
differences among treatments within and among experiments in each ploidy using a two-way 
analysis of variance (Statistical Analysis Software system Version 9 for Windows®, SAS 
Institute Inc., Cary, North Carolina). The model included GBR as the dependent variable, 
treatment as the fixed effect, and experiment and its interaction with the treatment as random 
effects. Also, comparison of GBR values at each stage was conducted to test for differences 
among the treatments within a stage, using a two-way analysis of variance (SAS system). The 
model included GBR as the dependent variable, treatment as the fixed effect, and stage and its 
interaction with the treatment as random effects. A Tukey-Kramer test was used to compare 
treatment differences, and these were considered to be significant at P < 0.05.  The GBR values 
met the assumption of normality and homogeneity of variance after square root transformation 
(Kutner et al. 2005). 
The levels of E2 in the hemolymph at different stages of gonadal maturation were 
compared using a one-way analysis of variance (SAS system). A Tukey-Kramer test was used to 
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compare concentrations differences among stages, and these were considered to be significant at 
P < 0.05.  
Comparisons of the total mean oocyte area of each treatment were conducted to test for 
differences among treatments within and among experiments using a two-way analysis of 
variance (SAS system). The model included oocyte area as the dependent variable, treatment as 
the fixed effect, and experiment and its interaction with the treatment as random effects. 
Differences were considered to be significant at P < 0.05 
RESULTS 
August 2003  
Triploid oysters (Initial evaluation) 
Indifferent gonads (Stage I) were generally observed for the triploid oysters evaluated at 
the beginning of the experiment. The GBR values were never higher than 10%, and this 
consisted only of follicular or indifferent gametic cells (Figure 4.3). Only 25% of the oysters had 
reduced or early maturing gonads (Stage III) and the rest were indifferent. 
Triploid oysters (Day 12)  
At day 12 of the experiment, the control group was characterized by reduced or early 
developed gonads (Stage III) with GBR values below 13%. No oysters were found at later 
development or spawning condition (Stages IV and V), but three oysters showed signs of  
having spawned (Figure 4.4), characterized by follicular disorganization and matured oocytes 
free in the lumina.  
 The low dose group was characterized by oysters at Stages I and III, but oysters at Stages 
IV, V, and VI were also present. Of the 19 female oysters in this group, one presented a late 
maturation development, and another had a gonad at a spawning condition with a GBR of 35% 
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(Figure 4.5). The oocytes present in this gonad were mature, non pendant from the follicular 
walls, and had large visible germinal vesicles 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 A & B Photomicrographs of a histological section showing the general pattern of 
gonadal development of triploid oysters at the beginning of the experiment (Stage I), August 
2003. CT: connective tissue; F: follicles; FC: follicular cells; M: mantle. 
 
  
 
 
 
 
 
 
 
Figure 4.4 A & B Photomicrographs of a histological section showing a spawned gonad (Stage 
VI), of a female triploid eastern oyster in the control treatment in August 2003. CT: connective 
tissue; F: follicles; M: mantle; Oc: oocytes. 
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Figure 4.5 A & B Photomicrographs of a histological section showing a gonad in spawning 
condition (Stage V) from a female triploid eastern oyster in the low dose treatment in August 
2003. Oocytes showed a prominent germinal vesicle. CT: connective tissue; DD: digestive 
diverticula; M: mantle; Oc: oocytes. 
 
 
The high dose group was characterized by oysters with reduced and early development 
gonads (Stage III), 83% of the oysters in this group were at this stage. No oysters at spawning 
condition were found on this group, but an oyster at the later development (stage IV) with some 
mature oocytes was found (Figure 4.6). Figure 4.7 shows the average GBR values and the 
percentage of oysters at each stage for the three treatments. 
There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatments GBR values 
were compared within stage. 
Diploid oysters (Initial evaluation) 
Late development and matured gonads (Stages IV and V) were the general conditions of 
the diploid oysters from this group at the beginning of the experiment (Figure 4.8). No oysters 
were found at earlier stages of gonadal development, and the average GBR for the oysters at 
Stage V was 43%.  
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Figure 4.6 A & B Photomicrographs of a histological section showing a gonad in late 
development condition (Stage IV) from a female triploid eastern oyster in the high dose 
treatment in August 2003. CT: connective tissue; F: follicles; M: mantle; O: oocytes. 
 
 
 
Diploid oysters (Day 12) 
At day 12 of the experiment, the oysters from the control group were found to be at Stage 
V with an average GBR of 39%. In the low dose treatment, oysters were found at different stages 
of gonadal development, from Stage III to Stage VI (Figure 4.9), but again the highest 
percentage of oysters (68%) was found at Stage V. In the high dose treatment 76% of the oysters  
were found to be at Stage V; oysters at Stage VI were also found, and one oyster presented an 
indifferent gonad. Figure 4.10 shows the average GBR values and the percentage of oysters at 
each stage for the three treatments. 
There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatments GBR values 
were compared within stage. 
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Figure 4.7 Gonadal assessment of the three experimental groups of triploid female eastern 
oysters evaluated in August 2003. Values represent the average percentage of gonad-to-body 
ratio   ± SE by gonadal stage. Pie charts show the percentage of oysters at each gonadal stage. 
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Figure 4.8 Photomicrographs of histological sections showing a gonad in: A) late development 
stage; B) spawning stage, from female diploid eastern oysters at the beginning of the experiment 
in August 2003. CT: connective tissue; F: follicles; G: gonad; M: mantle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Figure 4.9 Photomicrographs of histological sections showing a gonad in: A) early development, 
B) late development, C) spawning condition, and D) spawned condition, from female diploid 
eastern oysters in the low dose treatment in August 2003. CT: connective tissue; F: follicles; G: 
gonad; M: mantle; Oc: oocytes. 
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Figure 4.10 Gonadal assessment of the three experimental groups of diploid female eastern 
oysters evaluated in August, 2003. Values represent the average percentage of gonad-to-body 
ratio ± SE by gonadal stage. Pie charts show the percentage of oysters at each gonadal stage. 
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Diploid oysters not exposed to cytochalasin B (Initial evaluation) 
Only matured and spawned gonads (Stages V and VI) were found for the diploid oysters 
of this group at the beginning of the experiment, 80% of the oysters were at Stage V with an 
average GBR of 31%.  
Diploid oysters not exposed to CB (Day 12) 
At day 12 of the experiment, 72% of oysters in the control group were at Stage V, but 
oysters were found with developing gonads in Stages III and IV, and one oyster was at Stage VI. 
In the low dose treatment, 63% of the oysters were found to be at Stage V, one oyster was found 
at Stage IV, and the proportion of oysters at Stage VI increased in comparison to the control 
treatment (Figure 4.11). In the high dose treatment, 64% of the oysters were found to be at Stage 
V; the proportion of oysters at Stage VI decreased to 18%, and one oyster at Stage I was found. 
There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatments GBR values 
were compared within stage. 
The comparison between the GBR values of diploid oysters that were exposed to CB and 
those that were not, did not show any significant difference (P > 0.05). The gonad characteristics 
from both groups of oysters were the same at each stage of gonadal development, and the 
comparison of GBR within stages did not reveal any differences either.  
May 2004  
Triploid oysters (Initial evaluation)  
Reduced or early developed gonads were the general conditions of triploid oysters 
evaluated at the beginning of the experiment, 86% of the oysters were at Stage III, and the rest of 
the oysters were at Stage I. 
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Figure 4.11 Gonadal assessment of the three experimental groups of the diploid female eastern 
oysters not exposed to CB evaluated in August 2003. Values represent the average percentage of 
gonad-to-body ratio ± SE by gonadal stage. Pie charts show the percentage of oysters at each 
gonadal stage. 
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Triploid oysters (Day 9) 
At day 9 of the experiment, 84% of the oysters in the control group were characterized by 
reduced or early developed gonads (Stage III), with average GBR of 9% (Figure 4.12). One 
oyster was found at Stage IV and another had characteristics of a spawned gonad (Stage VI).  
The low dose treatment group was also characterized by oysters predominantly at Stage III with 
average GBR of 7%, but the proportion of oysters at this stage decreased to 73%. The proportion 
of oysters at Stage IV increased, and one oyster at Stage V with a GBR of 22% was found in this 
group (Figure 4.13). In the high dose treatment group the proportion of oysters at Stage III 
decreased to 69%, with average GBR of 12%. The rest of the oysters presented indifferent 
gonads. 
There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatments GBR values 
were compared within stage. 
Triploid oysters (Day 12) 
At day 12 of treatment, 87% of the oysters in the control group were characterized by 
reduced or early developed gonads (Stage III), with an average GBR of 7% (Figure 4.14). The 
low dose treatment group was also characterized by oysters at Stage III, with average GBR of 
6%, but the proportion of oysters at this stage decreased to 77%. No oysters were found beyond 
Stage IV. In the high dose treatment, the proportion of oysters at stage III decreased to 75%, with 
an average GBR of 9%. The rest of the oysters presented indifferent gonads.  
There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatments GBR values 
were compared within stage. Also, the GBR comparison within treatment of the groups 
evaluated at day 9 showed no significant differences from the groups evaluated at day 12.  
 63
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12 Gonadal assessment of the three experimental groups of triploid female eastern 
oysters evaluated in May 2004 at day 9 of the experiment. Values represent the average 
percentage of gonad-to-body ratio ± SE by gonadal stage. Pie charts show the percentage of 
oysters at each gonadal stage. 
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FIGURE 4.13 A & B Photomicrographs of a histological section showing a gonad in spawning 
condition (Stage V) from a female triploid eastern oyster in the low dose treatment at day 9th of 
experiment in May 2004. G: gonad; GC: genital canal; M: mantle; Oc: oocytes. 
 
 
 
 
Diploid oysters (Initial evaluation) 
Spawned  gonads (Stage VI) was the general condition of the diploid oysters evaluated at 
the beginning of the experiment on May of 2004, 75% of the oysters were at this stage with an 
average GBR of 16%. The rest of the oysters were at Stage V, and one oyster was at Stage I. 
Diploid oysters (Day 9) 
At day 9 of the experiment, 59% of the oysters in the control group presented Stage V 
gonads with average GBR values of 34%. The proportion of gonads at Stage VI decreased to 
27%, and one oyster was found at Stage III and another at Stage I. In the low dose treatment, 
66% of the oysters were found to be at Stage V, with average GBR value of 29%; the rest of the 
oysters were at Stage VI, and one oyster was found to be at Stage IV. In the high dose treatment, 
the proportion of oysters with gonads at Stage V decreased to 47%, but the proportion of oysters 
at Stage IV increased to 32%. One oyster was found to be at Stage VI, and 16% of the oysters 
had indifferent gonads (Figure 4.15).  
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Figure 4.14 Gonadal assessment of the three experimental groups of triploid female eastern 
oysters evaluated in May 2004 at day 12 of the experiment. Values represent the average 
percentage of gonad-to-body ratio ± SE by gonadal stage. Pie charts show the percentage of 
oysters at each gonadal stage. 
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Figure 4.15 Gonadal assessment of the three experimental groups of diploid female eastern 
oysters evaluated in May 2004 at day 9 of the experiment. Values represent the average 
percentage of gonad-to-body ratio ± SE by gonadal stage. Pie charts show the percentage of 
oysters at each gonadal stage. 
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There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatments GBR values 
were compared within stage. 
Diploid oysters (Day 12) 
At day 12 of the experiment, the control group was characterized by oysters with 
developing gonads, 50% of the oysters in this group were at Stages IV or III, with an average 
GBR values of 23%. The rest of the oysters were in Stage V with an average GBR value of 35%, 
and one oyster had an indifferent gonad. In the low dose treatment, the proportion of oysters in 
Stage V was the same as in the control, the proportion of oysters at Stage IV decreased, and 21% 
of the oysters in this group were found to be at Stage VI. In the high dose treatment 70% of the 
oysters were found to be at Stage V with an average GBR value of 36%, and the proportion of 
oysters at Stages IV and VI decreased (Figure 4.16)  
There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatments GBR values 
were compared within stage. Also, the GBR comparison within treatment of the groups 
evaluated at day 9 showed no significant differences from the groups evaluated at day 12.  
August 2004 
Triploid oysters (Initial evaluation) 
Reduced and early developed gonads were the general condition of the triploid oysters 
evaluated at the beginning of the experiment; 52% of the oysters were at Stage III, but a 
distribution of oysters at all stages of gonadal development was observed (Figure 4.17) 
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Figure 4.16 Gonadal assessment of the three experimental groups of diploid female eastern 
oysters evaluated in May 2004 at day 12 of the experiment. Values represent the average 
percentage of gonad-to-body ratio ± SE by gonadal stage. Pie charts show the percentage of 
oysters at each gonadal stage. 
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Figure 4.17 Gonadal assessment of female triploid eastern oysters evaluated at the beginning of 
the experiments in August 2004. Values represent average the percentage of gonad-to-body ratio 
± SE by gonadal stage. The pie chart shows the percentage of oysters at each gonadal stage. 
 
 
Triploid oysters (Day 12) 
At day 12 of the experiment, 79% of the oysters in the control group were characterized 
by reduced or early developed gonads (Stage III), with an average GBR value of 8%. The low 
dose treatment group was also characterized by oysters in Stage III with an average GBR value 
of 7%, but the proportion of oysters at this stage decreased to 70%. Oysters at Stage IV were also 
observed in this group with an average GBR value of 9%, and oysters at Stages VI and I were 
also present. In the high dose treatment, the proportion of oysters at Stage III decreased to 55%, 
with an average GBR value of 8%. The proportion of oysters in Stage IV remained the same as 
in the low dose group, but the average GBR increased to 16%. From the 20 female oysters in this 
group, 3 (15%) had gonads at Stage V (Figure 4.18), with average GBR values of 23%      
(Figure 4.19).  
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There were no significant differences (P > 0.05) among any of the treatments when the 
average GBR values were compared from each treatment, or when the treatments GBR values 
were compared within stage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.18 A & B Photomicrographs of a histological section showing a gonad in spawning 
condition (Stage V) from a female triploid eastern oyster in the high dose treatment at day 12 of 
experiment in August 2004. CT: connective tissue; G: gonad; M: mantle; OC: oocytes. 
 
 
 
 
Triploid oysters (Day 15) 
At day 15 of the experiment, 86% of the oysters in the control group were characterized 
by reduced or early developed gonads (Stage III), with average GBR values of 8%. The rest of 
the oysters were found at Stage IV. The low dose treatment was also characterized by oysters in 
Stage III with an average GBR value of 7%, but the proportion of oysters at this stage increased 
to 94%. In the high dose treatment, the proportion of oysters at Stage III decreased to 54%, with 
an average GBR value of 6%.  Six oysters (40%) developed Stage V gonads (Figure 4.20) with 
an average GBR value of 27% (Figure 4.21). Compared to the day 12 evaluation, this proportion 
increased 25%.  
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Figure 4.19 Gonadal assessment of the three experimental groups of triploid female eastern 
oysters evaluated in August 2004 at day 12 of the experiment. Values represent the average 
percentage of gonad-to-body ratio ± SE by gonadal stage. Pie charts show the percentage of 
oysters at each gonadal stage. 
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There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatments GBR values 
were compared within stage. Also, the GBR comparison within treatment of the groups 
evaluated at day 12 showed no significant differences from the groups evaluated at day 15.  
 
 
 
 
 
 
 
 
 
FIGURE 4.20 A & B Photomicrographs of a histological section showing a gonad in spawning 
condition (Stage V) from a female triploid eastern oyster in the high dose treatment at day 15 of 
experiment in August 2004. M: mantle; G: gonad; Oc: oocytes. 
 
 
 
Diploid oysters (Initial evaluation) 
All oysters evaluated at the beginning of the experiment had gonads at spawning 
condition (Stage V) with an average GBR value of 36%.  
Diploid oysters (Day 12) 
At day 12 of the experiment, 59% of the oysters in the control group presented gonads in 
Stage V with an average GBR value of 22%; 33% of the oysters were in Stage VI, and one oyster 
was in Stage IV. In the low dose treatment, the proportion of oysters in Stage V increased to 80% 
with an average GBR value of 23%, the rest of the oysters were in Stage IV with an average  
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Figure 4.21 Gonadal assessment of the three experimental groups of triploid female eastern 
oysters evaluated in August 2004 at day 15 of the experiment. Values represent the average 
percentage of gonad-to-body ratio ± SE by gonadal stage. Pie charts show the percentage of 
oysters at each gonadal stage. 
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GBR value of 17%. In the high dose treatment, the proportion of oysters with Stage V gonads 
decreased to 73%, but the proportion of oysters in Stage IV increased to 27% with an average 
GBR value of 21% (Figure 4.22).  
There were no significant differences (P > 0.05) among any of the treatments when the 
average GBR values from each treatment were compared, or when the treatment GBR values 
were compared within stages. 
Diploid oysters (Day 15) 
At day 15 of the experiment, 90% of the oysters in the control group were in Stage V 
with an average GBR value of 30%, and one oyster was in Stage VI. The low dose and high dose 
treatment groups presented only oysters with gonads at Stage V, although the high dose group 
had a 5% lower average GBR (Figure 4.23).  
There were no significant differences (P > 0.05) among any of the treatments when 
average GBR values from each treatment were compared, or when the treatment GBR values 
were compared within stages. Also, the GBR comparison within treatment of the groups 
evaluated at day 12 showed no significant differences from the groups evaluated at day 15.  
Estradiol Levels 
In the diploid oysters, the concentrations of E2 in general showed a gradual increase from 
indifferent to late developed gonads, and gradually decreased after that (Figure 4.24). In the 
triploid oysters the concentrations of E2 in general showed a gradual increase from indifferent to 
early developed gonads. From that point, the concentrations decreased, reaching their lowest 
levels in the oysters with gonads in spawning condition (Figure 4.24). There were no significant 
differences (P > 0.05) among the concentrations of E2 at the different gonadal stages for the 
triploid or diploid oysters. 
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Figure 4.22 Gonadal assessment of the three experimental groups of diploid female eastern 
oysters evaluated in August 2004 at day 12 of the experiment. Values represent the average 
percentage of gonad-to-body ratio ± SE by gonadal stage. Pie charts show the percentage of 
oysters at each gonadal stage. 
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Figure 4.23 Gonadal assessment of the three experimental groups of diploid female eastern 
oysters evaluated in August 2004 at day 15 of the experiment. Values represent the average 
percentage of gonad-to-body ratio ± SE by gonadal stage. The pie chart shows the percentage of 
oysters at each gonadal stage. 
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Figure 4.24 Changes in estradiol-17β at different stages of gonadal development of female 
eastern oysters. A: diploids (N = 99); B: triploids (N = 95). Values represent average 
concentration ± SE. 
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Oocyte Area 
No significant differences (P > 0.05) among the treatments were found in August 2003 
and 2004 for the oocyte area comparison (Table 4.2, 4.4). In May 2004 there were significant 
differences (P < 0.05) among the treatments at both days of evaluation (Table 4.3). In day 9 the 
control showed a higher oocyte area than the two E2 treatments and at day 12 the low dose group 
showed the highest oocyte area.  In the triploid oysters comparison of oocyte area was not 
possible because of lack of oysters at Stage V in every treatment. 
 
Table 4.2 Statistical comparison of the oocyte area among treatments for diploid eastern oysters 
in August 2003, (N =40) 
 Oocyte area (µm)  
Treatment Mean  SE* Comparison** 
Control 948.16 16.87 A 
Low dose 971.98 23.63 A 
High dose 1025.33 26.68 A 
*SE: Standard error, **Different letters indicate significant differences among treatment, as 
indicated by Tukey-Kramer multiple comparison test (α = 0.05).  
 
 
Table 4.3 Statistical comparison of the oocyte area among treatments for diploid eastern oysters 
in May 2004 on day 9 and 12 of the experiment, (N =80). 
 Oocyte area (µm)  
Treatment Mean  SE* Comparison** 
Control (day 9) 820.63 28.1 A 
Low dose (day 9) 670.36 13.95 B 
High dose (day 9) 685.35 17.51 B 
Control (day 12) 695.18 25 B 
Low dose (day 12) 792.15 11.44 A 
High dose (day 12) 741.94 13.21 Ab 
*SE; Standard error. **Different letters indicate significant differences among treatment, as 
indicated by Tukey-Kramer multiple comparison test (α = 0.05). 
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Table 4.4 Statistical comparison of the oocyte area among treatments for diploid eastern oysters 
in August 2004 on day 12 and 15 of the experiment, (N =61) 
 Oocyte area (µm)  
Treatment Mean  SE* Comparison** 
Control (day 12) 679.78 20.9 A 
Low dose (day 12) 650.42 16.34 A 
High dose (day 12) 658.55 13.73 A 
Control (day 15) 647.94 13.34 A 
Low dose (day 15) 662.18 12.89 A 
High dose (day 15) 662.39 13.12 A 
*SE; Standard error. **Different letters indicate significant differences among treatment, as 
indicated by Tukey-Kramer multiple comparison test (α = 0.05). 
 
 
Although none of the GBR values showed any significant differences among the 
treatments in the experiments, on average, the percentage of gonad-to-body ratio was higher in 
the oysters that were treated with E2 compared to the controls. In the diploid group, except for 
the experiment of August 2003, the GBR percentage of the control treatments was always lower 
than at least one of the E2 treatments (Figure 4.25 A). For the triploid oysters, except for the 
evaluation at day 9 of the experiment of May 2004, the GBR percentage of the control treatments 
was always lower than at least one of the E2 treatments, and the triploid oysters appeared to have 
responded better to the high dose treatment (Figure 4.25 B).  
DISCUSSION 
The goal of this study was to enhance ovarian maturation in triploid eastern oysters, with 
the purpose of producing viable oocytes that could be used for the production of tetraploid 
broodstocks. Accordingly, three dosages of the steroid estradiol-17β (E2) were tested in triploid 
and diploid eastern oysters and gonadal development was evaluated on qualitative and 
quantitative scales. 
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Figure 4.25 Average percentage of gonad-to-body ratio (GBR) of the eastern oysters for the 
three treatments in the three experiments. Control (triangles), low dose (circles), and high dose 
(squares). A: diploids, N = 99; B: triploids, (N = 95). 
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 Although the use of E2 to enhance gonadal maturation has been studied before in other bivalve 
species (Mori 1969), and the relation between E2 levels and its fluctuations at different stages of 
sexual maturation have been documented, to our knowledge this is the first time that exogenous 
E2 has been used to enhance gonadal development in diploid or triploid eastern oysters, and the 
first time the levels of E2 have been measured in diploid eastern oysters or in triploid oysters of 
any species.  
The use of E2 in triploid oysters showed no significant effects in the GBR values among 
the different treatments, or when the treatments were compared within stages in any of the 
experiments, although the general tendency of the GBR values was to be higher in the groups 
treated with the high dose of E2 than in the controls (Figure 4.25). While GBR may not be the 
best indicator to evaluate the effect of E2, a positive effect of E2 on gonadal maturation was 
observed when the percentages of oysters with gonads at Stages IV and V in the groups treated 
with E2 were compared to the control groups. 
In the experiment conducted in August of 2004, there was a stronger response of the 
triploid oysters to E2, compared to the other experiments of August 2003 and May 2004; with 
15% of the oysters found in Stage V at day 12 and 40% at day 15 at the high dose. The 
proportion of triploid oysters found in spawning condition (Stage V) in this experiment can be 
seen as relevant given that only 10 in 1600 (Supan et al. 2000a) was the proportion of mature 
triploid oysters that are expected to be found under normal conditions. The reason for the strong 
response of triploid oysters to E2 in this experiment is not clear, but it is possible that: 1) the 
longer exposure to the E2 had a greater effect on the gonadal maturation, and 2) the initial 
gonadal condition of the oysters, which had a higher percentage of oysters at Stage IV compared 
to the two previous experiments, favored a better response to the E2. For example, it has been 
suggested that E2 does not affect all oocytes and that a threshold size may be required before 
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oocyte growth can be stimulated by E2 in the starfish Asteria rubens (Schoenmakers et al. 1981). 
Estradiol probably does not affect the production of oocytes, but rather the maturation of the 
primary oocytes already present in the gonad, because E2 is one of the major factors that controls 
vitellogenesis (Li et al. 1998). In the eastern oyster, the threshold size of the oocytes for 
responsiveness to E2 is more likely to be found between the early and late gonadal development 
stages where primary oocytes begin the accumulation of nutrients (vitellogenesis). For example, 
it has been reported that for C. gigas the highest concentrations of protein, as a result of vitellin 
accumulation by the oocytes, was found just before the beginning of the spawning season (Li et 
al. 2000).  
The fact that triploid oysters with clear characteristics of having spawned were observed 
in all experimental groups indicates that regardless of the quality of the gonadal material or the 
amount of oocytes present in the gonad, the oysters followed a developmental sequence where 
the spawning of gametes in the gonads was the final step. This could be triggered by 
environmental and physiological factors that function independently of the gonadal condition. 
The same reproductive behavior was found in triploid Pacific oysters, where males and females 
showed characteristics of having spawned even when the gonads were not fully matured (Allen 
and Downing 1990).  This is important to consider because although triploid oysters were found 
at Stage VI even in the control groups in percentages as high as 18%, this does not necessarily 
indicate that these oysters went through a process of gonadal maturation and subsequent 
spawning as is assumed in a normal cycle of reproduction for diploid oysters.      
The exposure of oocytes to cytochalasin B at the time of the triploid induction had no 
effect on the process of subsequent gonadal maturation for the oysters that remained as diploids. 
Evidence of this was that the gonadal and gametic characteristics of the diploid oysters that were 
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exposed to CB during triploid induction were not different from the characteristics of the diploid 
oysters that were not exposed to CB in any of the three treatments or at the initial evaluation.  
The use of E2 in diploid oysters showed no significant effect on the gonadal maturation 
based on the GBR values for any of the experiments. This could have been as a result of the time 
of the year when the dosages were applied, when the diploid oysters were at a spawning 
condition or had already spawned. In either case the oocytes had already matured or there were 
not enough glycogen reserves to begin a new round of gonadal maturation. Regardless, the 
percentages of oysters with gonads at Stage V in the groups treated with E2 were higher than in 
the control groups in the last two experiments, suggesting that the oysters had a positive response 
to E2. 
The occurrence of E2 in the hemolymph of the triploid and diploid eastern oysters and 
fluctuations of titers with respect to the different stages of gonadal maturation, although  were 
not significantly different, suggested that: 1) E2 is synthesized by triploid and diploid eastern 
oysters, and 2) that the changes in titer correlate with oocyte maturation as a result of 
vitellogenesis. The profile of E2 concentrations found for the diploid oysters in these experiments 
was similar to those reported for other species of bivalves (Matsumoto et al. 1997) where the 
concentration of E2 starts to decrease when the animal enters the spawning stage. For the triploid 
oysters, the decline of E2 concentrations started at an earlier stage (Stage III) compared to the 
diploid oysters (Figure 5.24). The reason for the decrease of E2 in the triploid oysters at an earlier 
development stage (Stage III) than in the diploids is unclear, but may play a pivotal role in the 
reduced gonadal development observed in the triploid oysters.  
The fact that no significant differences among treatments were found when the oocyte 
area of diploid oysters was compared could have been as the result of the initial gonadal 
condition of the diploid oysters, where the majority of oocytes were already at a mature stage 
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with fully developed oocytes, and therefore, E2 had no effect on oocyte size. Another posible 
cause could have been the lack of sufficient nutrient reserves in the diploid oysters during the 
summer months, affecting the ability of the oocytes to incorporate vitellogenins to start a new 
round of vitellogenesis. Regardless, the use of oocyte areas to estimate the effect of E2 on 
ovarian maturation of eastern oysters was not a useful measuring tool in the months tested.  
In this study, diploid and triploid eastern oysters were capable of synthesizing     
estradiol-17β and the E2 concentrations varied with gonadal stage. The use of E2 in triploid 
oysters as a gonadal enhancer had no statistically significant effect on the GBR. The observation 
of oysters with matured gonads and in spawning condition was made only in the treated groups, 
and the percentage of oysters in later stages of maturation increased when the E2concentration 
was higher and the treatment was longer, suggesting that E2 had a positive effect on the oocyte 
maturation of triploid oysters, and thus merits further attention for use in the development of 
tetraploid broodstocks. 
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CHAPTER 5 – SUMMARY AND CONCLUSIONS 
  
The oyster industry in the state of Louisiana has traditionally been one of the most 
important in the United States and has consistently produced half the nation’s oyster supply 
(GOIP 2003). Despite large annual landings, the profitability of this industry fluctuates each year 
due to seasonal variations of meat yields that are caused by the natural reproductive period. This 
has generated interest in the production of triploid eastern oysters. Triploid oysters have an 
increased growth rate and higher meat yield  as a result of decreased fecundity because a large 
part of their energy reserves go to the production of meat rather than reproduction. The lack of a 
reliable and consistent method for the induction of triploidy in eastern oysters has been a major 
obstacle for the production of triploid eastern oysters on a commercial scale. The goal of this 
study was to evaluate ovarian maturation in triploid eastern oysters in response to the use of the 
hormone estradiol-17β (E2) to produce viable oocytes for the production of tetraploid 
broodstocks that can be used to produce natural triploid oysters.  
The results of this study showed that E2 was involved in ovarian maturation in triploid 
eastern oysters. Evidence of this was the incidence of oysters with mature gonads (Stage V) only 
in the group of oysters treated with E2. Although no significant differences were found when the 
gonad-to-body ratio (GBR) values of the different treatments were compared, the average GBR 
values of the E2 treatment groups was higher in 4 of the 5 evaluations conducted in the three 
experiments. Higher percentages of oysters at Stage V and greater GBR values were found when 
the treatments were longer (12 and 15 days) and when the E2 dosage was higher (75 ng/g wet 
weight). The use of E2 in diploid oysters showed no significant effect on gonadal maturation 
based on the GBR values for any of the experiments, but the percentages of oysters with gonads 
at Stages V and VI in the groups treated with E2 were greater than in the control groups, 
indicating a direct effect on maturation and spawning. 
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One of the most interesting results of this work was the observation that diploid and 
triploid eastern oysters were each capable of synthesizing E2, and that the levels of this hormone 
in the hemolymph varied in general with the stage of gonadal maturation, where the highest 
concentrations were found before the onset of spawning. This observation suggests that E2 plays 
an important role in the process of vitellogenesis and oocyte maturation in the eastern oyster. 
Previous to this, no published study had documented the occurrence of E2 in the eastern oyster. 
The use of appropriate methodologies to estimate reproductive condition in diploid and 
triploid eastern oysters was crucial to evaluate the effect of E2 on reproductive development. In 
this study, a methodology to estimate gonad-to-body ratio by image analysis was developed. The 
use of image analysis to quantitatively estimate gonadal development proved to be fast and 
reliable, and yield values comparable to existing comparable methodologies. In addition, a 
descriptive scale to stage reproductive development based on gonadal characteristics was 
created. The combination of these two measuring parameters facilitated the interpretation of the 
results in this study. 
 The overall response of triploid eastern oysters to E2 suggests that the use of this 
hormone had a positive effect on ovarian maturation. Expansion of the methodology to 
determine better dose response curves, dose frequency, and appropriate physicochemical 
parameters, would provide techniques directly applicable by oyster hatchery industries for the 
development of tetraploid broodstocks in the eastern oyster and could facilitate production of 
100% triploid eastern oysters, as a direct benefit for the Gulf oyster industry. 
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SOP - 1 Tissue collection 
Materials 
 
• Dissecting knife blade with handle (Pathco, Palo Alto, California) 
• Commercial oyster shucking knife 
• Tissue cassette (Omnisette, Fisher Scientific, Pittsburg, PA.) 
• 1-L plastic bottle with cap 
• Davidson solution (SOP-2) 
 
Procedures 
 
1. Open oyster carefully with a shucking knife and sever the adductor muscle from both valves. 
2. Make a perpendicular cut into the gill-labial palp junction; make a second cut 4 mm posterior 
(towards the adductor muscle) to the first cut (Figure A.1). 
3. Remove a 4-mm section and place into a tissue cassette with the junction of the labial palp-
gill junction side facing down.   
4. Place cassettes in a plastic bottle containing 750-ml of Davidson’s solution. 
5. Fixed sections can be taken to the LSU School of Veterinary Medicine for sectioning, 
staining, and mounting.  Sections should be 5-µm thick, approximately 1 mm from the gill-
labial palp junction, and stained with Gill’s hematoxylin and counter stained with eosin, and 
mounted on a glass slide.  
 
 
 
 
 
 
 
 
 
 
 
Figure A.1 Photograph of an oyster showing the location of the cuts for the histological section 
 
2nd cut
Gill-labial palp junction 
1st cut Adductor
muscle 
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SOP - 2 Davidson’s fixative 
Materials 
 
• 220 ml (w/w) formalin 37% [ FW = 30.03], (Fisher Scientific, Fair Lawn, New Jersey) 
• 330 ml ethanol 95%, (AAPER Alcohol, Shelbyville, Kentucky)  
• 115 ml acetic acid glacial [FW = 60.05 ], (Mallinckrodt Baker Inc. Phillipsburg, New Jersey) 
• 335 ml filtered sea water (same salinity from where the oysters were collected) 
• Glass bottle 
 
Procedures 
 
1. Mix all the reagents to produce a stock solution that can be stored for 6 months at room 
temperature. 
2. When ready to use the fixative, mix two parts of the stock solution with one part of filtered 
sea water.   
 
 
 
SOP - 3 Gonad-to-body ratio (transect method) 
Materials 
 
• Histological slide of an oyster transverse section 
• Compound microscope with vertical and horizontal scale 
 
Procedures 
 
1. Using the horizontal scale of the microscope, divide the histological section into ten 
equidistant transects from ventral to dorsal side of the section avoiding the curvature of the 
gonad (Figure A.1)  
2. Move the microscope pointer or crosshairs to transect 3 and position it at the outer membrane 
of the mantle, position M1 (Figure A.2). Record the position using the vertical scale 
3. Move downward (right to left) the gonad along the transect and with the vertical scale record 
the positions (Figure A.3) 
4. Determine the GBR value of that transect with the following formula: 
 
GBR = [(G1 – MG1) + (MG2 – G2)] / (M2 – M1) 
 
5. Average the GBR values of transects 3 to 8 to calculate the total GBR 
 
Oyster Total GBR = Σ GBR values transect 3-8 / 6 
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Figure A.2 Photomicrograph of a transverse histological section of an eastern oyster showing ten 
equidistant transects, M1: outer membrane of the mantle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.3 Division of layers of a transverse section through the mid-body region of an oyster. 
Each boundary has been labeled to simplify the calculation of the GBR. 
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SOP - 4 Gonad-to-body ratio (Image analysis methods) 
Materials 
 
• Digital scanner (Epson Perfection 1640SU, Epson America Inc. Long Beach, California) 
• Histological slide of an oyster transverse section 
• Software Adobe Photoshop 7.0 
• Digital pen and a drawing tablet (Hyper Pen 12000U, Aiptek Inc. Irvine, California) 
• Personal computer (Dell Precision workstation 360, Dell Inc. Austin, Texas)  
• Image analysis software Metaview 6.1 
 
Procedures 
 
1. Open the scanner software program (Epson smart panel) and select “scan to OCR 
application”. Inside that window select “A4” for paper size and “color” (300 dpi standard 
resolution) for scan mode and scan the histological slides. When finish, the scanner applications 
will automatically give the option of exporting the files to several programs. Choose the software 
Adobe Photoshop and save the images as a TIF file. 
2. Open the program Metaview 6.1 and open the file with the scanned image.  
3. Magnify the image twice using the magnifying glass icon in the toolbar options. 
4. From the toolbar open the “measurements” menu. 
5. From the measurements menu select “region measurements”. 
6. From the “region measurements” window select the “region” tab and choose “area”. 
7. From the toolbar select the “free trace tool” option (lasso icon).  
8. Go to the image, position the digital pen pointer on any place of the outer margin of the 
mantle and trace it following the outline of the body; this will be body area  (B), (Figure A.4). 
9. Position the digital pen pointer at any place of the outer margin of the gonad and trace it 
following the inner and outer outline of the gonad; this will be gonad area (G), (Figure A.4).    
10. Calculate the GBR by dividing B by G.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.4 Diagrammatic representation of the method used to determine the gonad-to-body 
ratio by area. Solid lines outline the body area; dashed lines outline the gonadal area, G: gonad 
area, B: body area. 
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SOP - 5 Hemolymph collection and storage 
Materials 
 
• Angle grinder (DeWalt 4-1/2 in, model DW402K) 
• Masonry cut-off wheel (115 x 2 mm) 
• Dissecting needle 
• 1-ml disposable syringe (Becton Dickinson Co. Franklin Lakes, New Jersey) 
• 23-ga needle (Becton Dickinson Co.) 
• 1.5-ml cryovials (Dot Scientific Inc. Lippincott Burton, Michigan)  
• Crushed ice 
• Liquid nitrogen 
 
Procedures 
 
1. With the angle grinder make a 5-mm notch on the shell, on the dorsal part of the oyster 
toward the posterior end next to the adductor muscle (Figure A.5). 
2. Through the notch, insert the syringe, when you encounter the adductor muscle, there will be 
resistance. Insert the needle 5-mm to 7-mm more, pull on the plunger to create suction and 
rotate the syringe until hemolymph starts to come out. Hemolymph is colorless and cloudy. 
3. Immediately transfer the hemolymph to a cryovial and put it in a ziplock bag on ice if the 
sample is to be used for ploidy analysis or put the criovial directly in liquid nitrogen if it is to 
be used for estradiol assay. Samples for ploidy analysis should be analyzed within 24 h; 
samples for estradiol assay can be stored at -80 C0 until analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.5 Diagram showing location of the shell notch  
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SOP - 6 Nile Tilapia and channel catfish blood collection and storage 
Materials 
 
• Tricane methanesulfonate (MS-222) (Argent Chemical Laboratories, Redmond, Washington) 
• 20-L bucket 
• 1-ml disposable syringe (Becton Dickinson Co. Franklin Lakes, New Jersey) 
• 23-ga needle(Becton Dickinson Co.) 
• Paper towels 
• Tank water 
• 1.5-ml plastic cryovial (Dot Scientific Inc. Lippincott Burton, Michigan)  
• Phosphate buffered solution Ca and Mg free (PBS) (Gibco, Grand Island, New York) 
• Dimethyl sulfoxide (DMSO) [FW = 294.11] (Fisher Scientific, Fair Lawn, New Jersey) 
• 35-µm filter screen 
• Anticoagulant solution (ACD) (Becton Dickinson, Franklin Lake, New Jersey) 
 
Procedure 
 
1. In a plastic bucket add 8 L of tank water and 200 mg/L for tilapia, Oreochromis nilotica, or 
300 mg/L for channel catfish, Ictalurus punctatus, of MS-222 and mix.  
2. Put the fish in the plastic bucket and wait 30 seconds for the fish to be anesthetized, if the 
fish is not anesthetized within 30 seconds, add 100 mg of MS-222. Continue doing this until 
the fish is anesthetized. 
3. Take the fish out of the water and lay it on paper towels. 
4. Collect the blood by caudal puncture with a syringe containing 10% of ACD (Figure A.6). 
5. Dilute the blood to a final concentration of 1x106 cell/ml with PBS containing 8% DMSO. 
6. Filter the diluted blood through a 35µm screen and aliquoted to cryovials. 
7. The blood can be store at -800C until analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.6 Extraction of blood by caudal puncture to a Nile tilapia.  
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SOP - 7 Propidium iodide solution 
Materials 
 
• Propidium iodide (PI) [FW = 668.41] (Sigma Chemical Co. St. Louis, Missouri) 
• Sodium citrate [FW = 294.11] (EM Science Inc., Gibbstown, New Jersey)  
• Triton X-100 (Mallinckrodt Specialty Chemicals Co., Paris, Kentucky) 
• RNase solution (SOP - 7) 
• Deionized water 
• 200-ml glass bottle 
• 1-ml disposable syringe (Becton Dickinson Co. Franklin Lakes, New Jersey) 
• 18-ga needle(Becton Dickinson Co.) 
• Aluminum foil  
• 35 µl Male Nile tilapia blood (SOP-6) 
 
Procedures 
 
1. Wrap the glass bottle with aluminum foil. 
2. Mix in the bottle 100 ml of deionized water, 5 mg of PI, 112 mg of sodium citrate, 0.1 ml of 
Triton X-100, and 100 µl of RNase solution. (Triton X-100 is viscous, so dispense with the 
syringe). 
3. The solution can be stored for 24 h with refrigeration and in the dark.   
4. For the sample preparation, mix 100 µl of oyster hemolymph, 35 µl of male Nile tilapia 
blood (SOP-6) and 500 µl of PI solution. 
5. Store samples in the dark for 15 min before analysis by flow cytometry. 
 
 
SOP - 8 RNase solution 
Materials 
 
• Tris (hydroxymethyl) aminomethane HCL [FW = 157.6] (Life Technologies, Grand Island, 
New York) 
• Sodium acetate [FW = 82.026] (Sigma Chemical Co. St. Louis, Missouri) 
• RNase from bovine pancrease (Sigma Chemical Co.) 
• Deionized water 
• 1.5-ml microcentrifuge  plastic vials (Dot Scientific Inc. Lippincott Burton, Michigan) 
 
Procedures 
1. Dissolve 1.58 g of Tris in 10 ml of deionized water. 
2. Dissolve 0.082 g of sodium acetate into 100 ml of deionized water. 
3. Dissolve 12.5 mg of RNase into 100 ml of the sodium acetate solution. 
4. Placed the RNase-sodium mixture into a heated water bath at 1000C for 15 min. Time the 
boiling from when the contents begin to bubble. 
5. Cool to room temperature. 
6. Adjust the pH to 7.4 by adding small volumes (~1.6 ml) of Tris. 
7. Dispense into aliquots of 10 µl into sterile microcentrifuge tubes.  
8. Store at -200C. 
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SOP - 9 Operation of the flowcytometer 
 
Materials 
 
• Flow cytometer (FACSCalibur, BD Biosciences, San Jose, California) 
• Sheath fluid (BD FACSFlow, BD Biosciences, San Jose, California) 
• CellQuest software version 1.0 (BD Biosciences, San Jose, California) 
• Personal computer (Power Mac G4, Apple Computer Inc. Cuperino, California) 
• Commercial Bleach 
• 5-ml Polystyrene round-bottom test tubes (BD Biosciences, Bedford, Massachusetts) 
 
Procedures 
 
Startup of the equipment 
1. In this order, turn on the flow cytometer and computer. 
2. Depressurized the waste and sheath tanks. 
3. Empty the waste reservoir tank and add ~200 ml of bleach and replace in the instrument. 
4. Fill the sheath tank (1/2 in below the upper limit) and replace in the instrument. 
5. Pressurized the waste and sheath tanks. 
6. Purge air bubbles from the sheet filter. 
7. Placed a test tube with 1 ml of fresh DI water on the sip tube and prime the flow cytometer. 
8. Allow the flow cytometer to warm up for 5 min. 
 
Operating the software 
1. Click on the apple icon in the upper left corner of the desktop and launch CellQuest. 
2. Go to “acquire” menu in the toolbar and select “connect to cytometer”. 
3. Go to “acquire” menu and select “parameter description” 
4. Go to “acquire” menu and select “counters” 
5. In the parameter description window select or create the file and folder were the data is going 
to be stored. 
6. Go to “plot’ menu in the toolbar and select “histogram plot”. 
7. In the “plot” menu go to “plot source” and select “acquisition analysis”. 
8. In the “plot” menu go to “parameter” and select “FL2A” (for DNA fluorescence in red 
spectrum). 
9. Go to “cytometer” menu in the toolbar and select “detector/amps” 
10. In the “detector/amps” window go to “mode” and select “LIN” (Mode = LIN). 
11. In the “detector/amps” window go to “DDM” and select parameter “FL2”. 
12. In the “detector/amps” and set up the voltage for FL2 at 511, this will produced a peak for 
the tilapia sample at the 400 channel and for a diploid oyster at the 200 channel. 
13. Put the sample in the machine. 
14. Click the acquire button in the “acquisition control” window to analyze the sample, make 
sure the setup box is unclick in order to save the data. 
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SOP - 10 Estradiol stock solutions 
Materials 
 
• β-estradiol 98% [FW = 272.39] (Sigma Chemical Co. St. Louis, Missouri) 
• Dimethyl sulfoxide (DMSO) [FW = 78.13] (Fisher Scientific, Fair Lawn, New Jersey) 
• Filtered sea water (0.45 µm) 
• 25-ml glass bottle with cap 
 
Procedure 
 
Control 
1. Filtered sea water with a concentration of 0.1 % of DMSO. 
 
Low dose solution 
1. Weigh 5 mg of β-estradiol and add to a glass bottle. 
2. Add 1.6 ml of DMSO.  
3. Dilute 1:1000 with 0.45-µm filtered sea water to obtained final concentration of 3125 ng/ml. 
 
High dose solution 
1. Weigh 10 mg of β-estradiol and add to a glass bottle. 
2. Add 1.6 ml of DMSO. 
3. Dilute 1:1000 with 0.45-µm filtered sea water to obtained final concentration of 6250 ng/ml. 
 
 
 
Table A.1 Injection volumes of estradiol-17β 
Shell height 
(mm) 
Estimated body 
average weight* 
(g) 
Volume injected 
(ml) 
70-80 13.6 0.15 
81-90 17.0 0.20 
91-100 20.4 0.25 
101-110 23.6 0.30 
111-120 26.9 0.35 
121-130 30.2 0.40 
131-140 33.5 0.45 
141-150 36.8 0.50 
*Regression shown in Chapter 4 
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SOP – 11 Oocyte area measurements 
Materials 
 
• Digital scanner (Epson Perfection 1640SU, Epson America Inc. Long Beach, California) 
• Histological slide of an oyster transverse section 
• Personal computer (Dell Precision workstation 360, Dell Inc. Austin, Texas) 
• Image analysis software Scion Image Beta 4.02 
• Compound microscope (Nikon Photoshot, Tokyo, Japan) 
• Microscope digital camera (Costar CV 730, Southern Imaging Inc. Carrollton, Texas) 
 
Procedures 
 
1. Place the histological slide in the microscope; take a photomicrograph of a gonad section at 
100x magnification. Save the images as a TIF file. 
2. Open the program Scion Image and import the scanned image.  
3. Set scale to 1.115 pixels/micrometers. 
4. From the toolbar open the “map” option and adjust the contrast using the sliding scale with B 
or C on it. Adjust until the oocytes appear darker and more crisp then the surroundings (work 
with the black and white picture while comparing to original picture). 
5. Go to the “analyze” menu and select “options”. 
6. Select “measurement of area”, include interior holes, and auto-measure. 
7. From the toolbar menu select the “wand” icon and start selecting the oocytes to be measure 
by clicking them. Make sure a measurement number appears in the middle of the oocyte to 
ensure that you measured only the oocyte (measurements should be around 600-1400 μm). 
8. Select 50 oocytes from the whole picture. The criteria to select oocytes are circular oocyte 
shape, clear germinal vesicle, and a visible nucleolus. 
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APPENDIX B 
UNANALYZED DATA 
 
Table B.1 Gonad-to-body ratio (GBR) and time spend by the different methods (Chapter 2). 
Transect 
method Time 
Total 
area Time 
Area w/o 
gills Time 
Area w/o 
curvature Time *Gonad  
GBR (min) GBR (min) GBR (min) GBR (min) stage 
0.32707 13.13 0.39687 2.65 0.41910 2.10 0.34794 1.73 V 
0.33084 14.80 0.37277 3.45 0.39906 2.92 0.33189 2.08 V 
0.12717 18.28 0.20688 4.33 0.21268 3.67 0.14455 2.25 V 
0.05255 17.93 0.04670 4.03 0.09839 3.92 0.06585 2.98 III 
0.12235 17.78 0.16954 3.25 0.18931 2.65 0.13939 1.92 VI 
0.34323 17.70 0.42721 3.42 0.43395 3.03 0.33269 2.07 V 
0.17497 17.42 0.23538 3.10 0.25238 2.92 0.18537 2.15 V 
0.24746 13.03 0.20437 2.13 0.21253 1.98 0.20041 1.02 V 
0.21854 17.33 0.27090 1.73 0.29351 1.62 0.21525 0.88 V 
0.20463 16.47 0.19539 2.05 0.21210 2.12 0.22651 0.85 V 
0.28585 14.65 0.33620 3.03 0.34936 2.88 0.28540 1.75 V 
0.29713 13.48 0.27124 2.67 0.31567 2.02 0.27385 0.88 V 
0.15792 15.52 0.20105 3.95 0.21233 3.17 0.19979 2.58 VI 
0.20547 17.58 0.23896 2.38 0.24756 1.83 0.20547 0.73 V 
0.21742 17.47 0.30759 3.28 0.32371 3.05 0.22672 2.25 V 
0.19011 17.82 0.23807 3.62 0.24804 3.60 0.24211 1.63 V 
0.26281 14.27 0.35842 1.47 0.37983 1.38 0.34676 0.60 V 
0.20988 19.27 0.18563 1.35 0.20128 1.18 0.15847 0.63 IV 
0.31618 15.07 0.35764 1.67 0.38909 1.48 0.36488 0.60 V 
0.38128 13.30 0.41484 1.20 0.45036 0.97 0.36493 0.45 V 
0.38558 13.45 0.41603 0.95 0.43944 0.90 0.36250 0.47 V 
0.22801 14.47 0.28766 3.75 0.30829 3.40 0.21231 1.38 V 
0.19435 15.28 0.23028 3.25 0.25142 2.95 0.18616 1.62 V 
0.28214 13.47 0.34622 3.50 0.36391 3.12 0.25170 1.78 V 
0.11891 17.72 0.08882 5.22 0.09196 4.83 0.06683 2.20 III 
0.32114 15.07 0.30315 3.68 0.33282 3.88 0.34131 2.23 V 
0.29337 14.72 0.23128 5.82 0.25306 4.92 0.23971 2.95 V 
0.18577 17.70 0.17816 3.55 0.17874 3.48 0.17259 2.28 V 
0.27717 14.33 0.37791 3.88 0.41760 3.35 0.28044 1.97 V 
0.22673 16.48 0.29356 3.32 0.30501 3.20 0.23278 1.98 V 
0.12286 17.27 0.18312 3.78 0.18988 2.45 0.13939 1.45 IV 
0.27079 13.27 0.32560 4.40 0.32131 3.25 0.30944 1.47 V 
0.07157 13.88 0.09903 4.08 0.10423 3.48 0.07805 1.87 III 
0.17012 16.98 0.17476 4.10 0.18559 3.47 0.15796 1.85 VI 
0.19770 13.75 0.23757 3.92 0.27919 3.27 0.25424 1.48 V 
0.12003 12.00 0.08141 2.17 0.09081 1.85 0.08481 0.90 III 
0.14462 11.47 0.20756 4.27 0.22436 3.55 0.16835 1.20 V 
0.24728 11.12 0.28528 1.68 0.29357 1.72 0.29273 1.03 V 
0.25887 13.72 0.24227 3.15 0.26553 2.72 0.26090 2.17 IV 
0.08217 12.00 0.10345 1.35 0.11068 1.18 0.11170 0.60 VI 
0.18790 11.42 0.16127 2.05 0.20988 1.70 0.17014 1.03 VI 
0.04780 13.88 0.04866 4.38 0.06328 3.92 0.05012 3.00 III 
0.10200 12.85 0.13473 3.15 0.16932 2.73 0.09645 2.02 IV 
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Table B.1 continued 
III: early development, IV: late development, V: spawning, VI: advanced spawning and 
regression 
 
 
 
Table B.2 Unanalyzed data from diploid oysters evaluated in August 2003 and May and August 
2004 (Chapter 3). 
Oyster No Ploidy Stage* GBR** Oyster No Ploidy Stage* GBR** 
1 2N I 0.057 43 2N V 0.22214 
2 2N I 0.1009 44 2N V 0.23715 
3 2N I 0.1411 45 2N V 0.24189 
4 2N I 0.0187 46 2N V 0.24366 
5 2N I 0.0519 47 2N V 0.24620 
6 2N I 0.0701 48 2N V 0.26969 
7 2N III 0.06941 49 2N V 0.27353 
8 2N III 0.07599 50 2N V 0.28000 
9 2N III 0.0956 51 2N V 0.28205 
10 2N III 0.1665 52 2N V 0.28640 
11 2N III 0.1864 53 2N V 0.29681 
12 2N IV 0.10938 54 2N V 0.29934 
13 2N IV 0.30354 55 2N V 0.30023 
14 2N IV 0.25777 56 2N V 0.30413 
15 2N IV 0.22772 57 2N V 0.30970 
16 2N IV 0.11324 58 2N V 0.31452 
17 2N IV 0.2727 59 2N V 0.31165 
18 2N IV 0.3025 60 2N V 0.31855 
19 2N IV 0.1143 61 2N V 0.31922 
20 2N IV 0.1349 62 2N V 0.32094 
21 2N IV 0.1511 63 2N V 0.32385 
22 2N IV 0.2111 64 2N V 0.32719 
23 2N IV 0.2204 65 2N V 0.33063 
24 2N IV 0.2480 66 2N V 0.33202 
25 2N IV 0.2568 67 2N V 0.33465 
26 2N IV 0.2588 68 2N V 0.33907 
27 2N IV 0.2652 69 2N V 0.34306 
28 2N IV 0.2874 70 2N V 0.34735 
29 2N IV 0.3211 71 2N V 0.34869 
30 2N IV 0.134439 72 2N V 0.34987 
31 2N IV 0.134883 73 2N V 0.35232 
32 2N IV 0.167395 74 2N V 0.35451 
33 2N IV 0.181063 75 2N V 0.35595 
34 2N IV 0.234926 76 2N V 0.35773 
35 2N IV 0.150976 77 2N V 0.35954 
36 2N IV 0.140386 78 2N V 0.36108 
37 2N IV 0.184481 79 2N V 0.36498 
38 2N IV 0.213272 80 2N V 0.36700 
0.12510 11.45 0.10880 2.73 0.15370 2.28 0.11436 1.85 IV 
0.22146 14.27 0.24873 3.68 0.27551 3.08 0.21453 2.62 V 
0.16987 12.78 0.16662 3.37 0.21330 2.98 0.17153 2.20 VI 
0.23015 11.90 0.25300 2.73 0.27335 2.27 0.22438 1.78 V 
0.19485 13.37 0.20037 3.52 0.22096 2.92 0.19531 2.38 IV 
0.21037 11.75 0.19520 2.33 0.22291 1.93 0.21317 1.62 IV 
0.21632 10.00 0.20510 2.07 0.24688 1.55 0.21938 0.63 V 
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39 2N IV 0.303985 81 2N V 0.36927 
40 2N IV 0.302075 82 2N V 0.37163 
41 2N IV 0.190676 83 2N V 0.37386 
85 2N V 0.38154 130 2N V 0.34474 
86 2N V 0.38227 131 2N V 0.36474 
87 2N V 0.38739 132 2N V 0.36502 
88 2N V 0.38770 133 2N V 0.36780 
89 2N V 0.39244 134 2N V 0.36956 
90 2N V 0.39569 135 2N V 0.40724 
91 2N V 0.39990 136 2N V 0.42736 
92 2N V 0.41301 137 2N V 0.49471 
93 2N V 0.41373 138 2N V 0.50900 
94 2N V 0.41447 139 2N V 0.53622 
95 2N V 0.41617 140 2N V 0.22832 
96 2N V 0.42579 141 2N V 0.21328 
97 2N V 0.42680 142 2N V 0.21226 
98 2N V 0.43081 143 2N V 0.23658 
99 2N V 0.43646 144 2N V 0.23435 
100 2N V 0.43654 145 2N V 0.21883 
101 2N V 0.44513 146 2N V 0.20509 
102 2N V 0.46094 147 2N V 0.20421 
103 2N V 0.47324 148 2N V 0.21640 
104 2N V 0.47365 149 2N V 0.26257 
105 2N V 0.20415 150 2N V 0.28310 
106 2N V 0.28770 151 2N V 0.27333 
107 2N V 0.33549 152 2N V 0.29648 
108 2N V 0.32097 153 2N V 0.25535 
109 2N V 0.27292 154 2N V 0.30080 
110 2N V 0.44507 155 2N V 0.33657 
111 2N V 0.27485 156 2N V 0.26017 
112 2N V 0.35748 157 2N V 0.33453 
113 2N V 0.23768 158 2N V 0.23652 
114 2N V 0.36314 159 2N V 0.38796 
115 2N V 0.29069 160 2N V 0.25226 
116 2N V 0.44201 161 2N V 0.36704 
117 2N V 0.32083 162 2N V 0.25219 
118 2N V 0.44538 163 2N V 0.26176 
119 2N V 0.21499 164 2N V 0.28867 
120 2N V 0.24487 165 2N V 0.39924 
121 2N V 0.25621 166 2N V 0.29847 
122 2N V 0.28083 167 2N V 0.32776 
123 2N V 0.30104 168 2N V 0.21709 
124 2N V 0.30280 169 2N V 0.22176 
125 2N V 0.32069 170 2N V 0.28545 
126 2N V 0.32671 171 2N V 0.20266 
127 2N V 0.33129 172 2N V 0.33864 
128 2N V 0.34171 173 2N V 0.25092 
129 2N V 0.34239 174 2N V 0.29890 
175 2N V 0.22100 195 2N VI 0.19509 
176 2N V 0.34171 196 2N VI 0.16618 
177 2N V 0.38154 197 2N VI 0.19801 
178 2N V 0.25092 198 2N VI 0.19920 
179 2N V 0.34401 199 2N VI 0.27137 
180 2N V 0.25795 200 2N VI 0.05633 
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181 2N V 0.28650 201 2N VI 0.07074 
182 2N V 0.25999 202 2N VI 0.10570 
183 2N V 0.27197 203 2N VI 0.20845 
184 2N V 0.25742 204 2N VI 0.22065 
185 2N V 0.31553 205 2N VI 0.20966 
186 2N V 0.29290 206 2N VI 0.21149 
187 2N V 0.44135 207 2N VI 0.22452 
188 2N VI 0.05128 208 2N VI 0.10276 
189 2N VI 0.07953 209 2N VI 0.11440 
190 2N VI 0.08720 210 2N VI 0.16387 
191 2N VI 0.09193 211 2N VI 0.20063 
192 2N VI 0.09541 212 2N VI 0.07130 
193 2N VI 0.10966 213 2N VI 0.13331 
194 2N VI 0.18462 214 2N VI 0.18139 
*Gonadal stage, **Gonad-to-Body Ratio 
 
 
 
Table B.3 Unanalyzed data from triploid oysters evaluated in August 2003 and May and August 
2004 (Chapter 3). 
Oyster No Ploidy *Stage **GBR Oyster No Ploidy *Stage **GBR 
1 3N I 0.025051 43 3N II 0.051636 
2 3N I 0.020314 44 3N II 0.051638 
3 3N I 0.029374 45 3N II 0.052265 
4 3N I 0.042325 46 3N II 0.052301 
5 3N I 0.043852 47 3N II 0.052301 
6 3N I 0.044111 48 3N II 0.052754 
7 3N I 0.04745 49 3N II 0.053064 
8 3N I 0.048612 50 3N II 0.053286 
9 3N I 0.05662 51 3N II 0.053538 
10 3N I 0.062612 52 3N II 0.053575 
11 3N I 0.063107 53 3N II 0.05376 
12 3N I 0.063456 54 3N II 0.053798 
13 3N I 0.067978 55 3N II 0.05432 
14 3N I 0.071697 56 3N II 0.055111 
15 3N I 0.073855 57 3N II 0.055653 
16 3N I 0.074918 58 3N II 0.055691 
17 3N I 0.100562 59 3N II 0.055941 
18 3N I 0.104087 60 3N II 0.056488 
19 3N I 0.116591 61 3N II 0.057242 
20 3N I 0.124176 62 3N II 0.057334 
21 3N I 0.140743 63 3N II 0.057539 
22 3N II 0.015798 64 3N II 0.057572 
23 3N II 0.031618 65 3N II 0.057621 
24 3N II 0.032131 66 3N II 0.057809 
25 3N II 0.034425 67 3N II 0.057838 
26 3N II 0.034721 68 3N II 0.058411 
27 3N II 0.036009 69 3N II 0.05869 
28 3N II 0.036581 70 3N II 0.058811 
29 3N II 0.036962 71 3N II 0.059192 
30 3N II 0.037264 72 3N II 0.059209 
31 3N II 0.037271 73 3N II 0.059686 
32 3N II 0.037419 74 3N II 0.060214 
33 3N II 0.037604 75 3N II 0.060829 
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34 3N II 0.037636 76 3N II 0.061026 
35 3N II 0.038392 77 3N II 0.061191 
36 3N II 0.038967 78 3N II 0.061248 
37 3N II 0.04036 79 3N II 0.061316 
38 3N II 0.042356 80 3N II 0.061837 
39 3N II 0.044167 81 3N II 0.062297 
40 3N II 0.045133 82 3N II 0.062594 
41 3N II 0.045697 83 3N II 0.062881 
42 3N II 0.046754 84 3N II 0.063413 
85 3N II 0.065225 129 3N II 0.098545 
86 3N II 0.065715 130 3N II 0.099146 
87 3N II 0.066373 131 3N II 0.100146 
88 3N II 0.066809 132 3N II 0.100166 
89 3N II 0.067539 133 3N II 0.101227 
90 3N II 0.067914 134 3N II 0.103184 
91 3N II 0.068182 135 3N II 0.105282 
92 3N II 0.069724 136 3N II 0.110816 
93 3N II 0.070049 137 3N II 0.111294 
94 3N II 0.072877 138 3N II 0.112359 
95 3N II 0.07434 139 3N II 0.116661 
96 3N II 0.074359 140 3N II 0.117851 
97 3N II 0.075784 141 3N II 0.126032 
98 3N II 0.075844 142 3N II 0.128878 
99 3N II 0.076021 143 3N II 0.132016 
100 3N II 0.076248 144 3N II 0.132355 
101 3N II 0.076657 145 3N II 0.13247 
102 3N II 0.077361 146 3N II 0.133313 
103 3N II 0.077597 147 3N II 0.14409 
104 3N II 0.077921 148 3N II 0.147425 
105 3N II 0.079141 149 3N II 0.164098 
106 3N II 0.079261 150 3N II 0.172512 
107 3N II 0.081028 151 3N II 0.173714 
108 3N II 0.081416 152 3N III 0.070565 
109 3N II 0.081452 153 3N III 0.037327 
110 3N II 0.08267 154 3N III 0.040641 
111 3N II 0.084714 155 3N III 0.045375 
112 3N II 0.08484 156 3N III 0.049265 
113 3N II 0.085273 157 3N III 0.053193 
114 3N II 0.085944 158 3N III 0.056274 
115 3N II 0.086717 159 3N III 0.058425 
116 3N II 0.086886 160 3N III 0.068509 
117 3N II 0.086941 161 3N III 0.074274 
118 3N II 0.087862 162 3N III 0.074741 
119 3N II 0.088357 163 3N III 0.076952 
120 3N II 0.0889 164 3N III 0.080504 
121 3N II 0.090999 165 3N III 0.085895 
122 3N II 0.091317 166 3N III 0.085922 
123 3N II 0.091346 167 3N III 0.09406 
124 3N II 0.093255 168 3N III 0.104879 
125 3N II 0.093778 169 3N III 0.107642 
126 3N II 0.094047 170 3N III 0.109398 
127 3N II 0.094124 171 3N III 0.120121 
128 3N II 0.09454 172 3N III 0.14185 
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Table B.4 Unanalyzed data from initial evaluation of the experiment conducted in August 2003 
(Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
1 Initial  3N 113 16.23 I 0.0690 I N/D 
2 Initial  3N 95.2 14.73 I 0.0744 I N/D 
3 Initial  3N 98 11.78 F 0.0772 III N/D 
4 Initial  3N 99 12.4 I 0.0845 I N/D 
1 Initial  2N 87.5 8.96 F 0.1904 IV N/D 
2 Initial  2N 94 12.07 F 0.4462 V N/D 
3 Initial  2N 75 5.56 F 0.1621 VI N/D 
4 Initial  2N 87.2 11.23 F 0.4061 V N/D 
5 Initial  2N 92.5 7.35 F 0.1721 IV N/D 
1 Initial 2N* 95 13.24 F 0.2466 V N/D 
2 Initial 2N* 91 13.27 F 0.4109 V N/D 
3 Initial 2N* 96.2 7.47 F 0.1891 VI N/D 
4 Initial 2N* 90 8.65 F 0.2593 V N/D 
5 Initial 2N* 72.1 9.83 F 0.3221 V N/D 
*Diploid oysters not exposed to cytochalasin B  
 
 
 
Table B.5 Unanalyzed data from triploid oysters evaluated in August 2003 (Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
A1 Control 3N 97.2 8.28 F 0.12887 III 116.268 
A5 Control 3N 92.2 10.89 F 0.06229 III 37.171 
A7 Control 3N 101.2 13.66 F 0.08671 III 33.663 
A8 Control 3N 73 10.89 F 0.05841 III 16.327 
A9 Control 3N 92.4 10.85 F 0.05808 VI 13.988 
A10 Control 3N 101 9.38 F 0.07287 III 30.142 
A15 Control 3N 92 21.25 F 0.05920 III 24.607 
A16 Control 3N 98 14.73 F 0.08589 III 24.969 
A18 Control 3N 85.6 14.8 F 0.05226 III 28.042 
A21 Control 3N 112.4 15.63 F 0.07178 VI 25.062 
A22 Control 3N 87.2 9.88 F 0.03161 III 27.939 
A24 Control 3N 109.1 16.61 F 0.07665 III 32.647 
A26 Control 3N 93.5 10.15 F 0.07759 III 14.786 
A28 Control 3N 85.7 10.13 F 0.12012 III 17.162 
A32 Control 3N 95.5 14.93 F 0.05724 III 20.928 
A33 Control 3N 83.2 11.39 F 0.09406 III 21.309 
A34 Control 3N 91.4 12.37 F 0.05511 III 23.714 
A36 Control 3N 92 17.42 F 0.04235 III 20.142 
A37 Control 3N 83 11.6 F 0.06588 VI 21.568 
A39 Control 3N 100 6.5 I 0.02505 I 19.258 
B4 Control 3N 93 12.77 I 0.04745 I 21.854 
B8 Low 3N 88 8.57 F 0.10487 III N/D 
B9 Low 3N 96 19.77 F 0.05662 I  N/D 
B11 Low 3N 89.6 12.93 F 0.07434 III N/D 
B13 Low 3N 80 7.74 F 0.05753 III N/D 
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B14 Low 3N 88.6 11.39 F 0.08484 III N/D 
B19 Low 3N 84.7 10.4 F 0.07101 IV N/D 
B20 Low 3N 82.4 13.58 F 0.06962 VI N/D 
B21 Low 3N 94.6 NW F 0.05641 VI N/D 
B23 Low 3N 86 13.53 F 0.04775 III N/D 
B24 Low 3N 99 15.14 F 0.05033 VI N/D 
B29 Low 3N 91.2 9.19 I 0.06310 I N/D 
B34 Low 3N 106.1 9.99 I 0.04385 I N/D 
B35 Low 3N 98.5 15.78 F 0.04416 III N/D 
B38 Low 3N 115.2 13.96 F 0.04234 VI N/D 
C3 Low 3N 83.5 8.4 F 0.05115 III N/D 
C5 Low 3N 95.5 17.08 F 0.07792 III N/D 
C8 Low 3N 88.7 12.31 F 0.05919 III N/D 
C13 Low 3N 87 8.79 F 0.35885 V N/D 
C14 Low 3N 92 13.32 F 0.03760 III N/D 
C15 High 3N 90 7 F 0.09099 III N/D 
C16 High 3N 84.8 15.36 F 0.08102 III N/D 
C17 High 3N 110 16.59 F 0.06424 VI N/D 
C18 High 3N 80 10.75 F 0.05757 III N/D 
C21 High 3N 96.5 11.86 F 0.04794 VI N/D 
C23 High 3N 91.4 10.74 F 0.04569 III N/D 
C25 High 3N 89.6 9.76 F 0.05306 III N/D 
C27 High 3N 91.4 8.76 F 0.13235 III N/D 
C28 High 3N 109.3 9.97 F 0.01579 III N/D 
C32 High 3N 91.6 11.67 F 0.06637 III N/D 
C37 High 3N 93 11.01 F 0.05968 III N/D 
C38 High 3N 88.5 17.28 F 0.06522 III N/D 
C39 High 3N 84.9 10.37 F 0.00043 III N/D 
C40 High 3N 85.7 14.91 F 0.05869 III N/D 
D1 High 3N 83.2 9.89 F 0.07056 III N/D 
D3 High 3N 90 11.04 F 0.03896 III N/D 
D5 High 3N 92.4 15.91 F 0.05230 III N/D 
D6 High 3N 101.3 12.66 F 0.05353 III N/D 
D7 High 3N 92.4 10.4 F 0.05163 III N/D 
D9 High 3N 93 18.56 F 0.03600 III N/D 
D11 High 3N 91.6 12.97 F 0.08786 III N/D 
D12 High 3N 106.5 16.97 F 0.10460 IV N/D 
D13 High 3N 82 12.57 F 0.08319 VI N/D 
 
 
 
Table B.6 Unanalyzed data from diploid oysters evaluated in August 2003 (Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
A2 Control 2N 85.5 9.38 F 0.43081 V 35.641 
A12 Control 2N 90 9.85 F 0.45543 V 22.764 
A13 Control 2N 96 9.49 F 0.33907 V 77.961 
A14 Control 2N 92.5 7.58 F 0.43646 V 20.177 
A19 Control 2N 74.8 7.63 F N/D V 44.05 
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A23 Control 2N 88.8 8.27 F 0.44512 V 25.441 
A29 Control 2N 90 11.35 F 0.36927 V 10.476 
A31 Control 2N 97.6 2.3 F 0.34869 V 41.491 
A38 Control 2N 78.6 7.93 F 0.47365 V 28.401 
B1 Control 2N 78.2 8.52 F 0.36497 V 16.918 
B3 Control 2N 98.1 11.47 F 0.35451 V 20.548 
B6 Control 2N 86.4 6.5 F 0.30412 V 20.412 
B15 Control 2N 112.5 10.98 F 0.23727 V 14.68 
B17 Control 2N 119 7.79 F 0.31922 V 22.191 
B18 Control 2N 89.1 8.74 F 0.39243 V 31.649 
B25 Control 2N 85.1 10.99 F 0.43654 V 13.94 
B31 Control 2N 88 8.22 F 0.34305 V 36.039 
B32 Low 2N 88.2 11.52 F 0.19919 V N/D 
B33 Low 2N 85.5 12.12 F 0.33063 V N/D 
B37 Low 2N 95.2 13.58 F 0.39569 V N/D 
B39 Low 2N 92 13.85 F 0.37163 V N/D 
C6 Low 2N 78 11.59 F 0.41446 V N/D 
C9 Low 2N 88.3 6.08 F 0.30353 IV N/D 
C10 Low 2N 92.4 8.88 F N/D V N/D 
C12 Low 2N 100.7 14.36 F 0.07953 VI N/D 
C19 Low 2N 88.2 8.3 F 0.06941 III N/D 
C34 Low 2N 85.9 13.55 F 0.33202 V N/D 
C35 Low 2N 100 10.65 F 0.32385 V N/D 
D4 Low 2N 106.1 12.25 F 0.24189 V N/D 
D10 Low 2N 105.1 18.3 F 0.07598 III N/D 
D16 Low 2N 92.3 9.92 F 0.42579 V N/D 
D17 Low 2N 92.8 9.96 F 0.36108 V N/D 
D19 Low 2N 93.1 13.66 F 0.27352 V N/D 
D23 High 2N 91.3 13.04 F 0.26968 V N/D 
D26 High 2N 91 10.65 F 0.47324 V N/D 
D31 High 2N 95.7 17.21 F 0.08719 VI N/D 
D32 High 2N 100.7 9.2 F 0.09193 VI N/D 
D34 High 2N 100.7 9.27 F 0.46094 V N/D 
E1 High 2N 99.4 9.91 F 0.31451 V N/D 
E2 High 2N 105.4 10.53 F 0.37453 V N/D 
E4 High 2N 105.5 11.53 F 0.31165 V N/D 
E9 High 2N 93 8.64 F 0.35595 V N/D 
E10 High 2N 90 8.77 F 0.32093 V N/D 
E11 High 2N 91.5 9.76 F 0.34987 V N/D 
E12 High 2N 82 5.8 F 0.11016 I N/D 
E14 High 2N 108.4 10.83 F 0.38738 V N/D 
E17 High 2N 102.3 8.32 F 0.05128 VI N/D 
E23 High 2N 84.2 11.22 F 0.24619 V N/D 
E33 High 2N 85.1 9.91 F 0.38769 V N/D 
E34 High 2N 105 11.25 F 0.42680 V N/D 
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Table B.7 Unanalyzed data from diploid oysters not exposed to cytochalasin B, evaluated in 
August 2003 (Chapter 4). 
 
 
 
 
 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad Estradiol 
   (mm) (g)   Stage (pg/ml) 
G1 Control 2N 92 8.42 F 0.13350 VI N/D 
G2 Control 2N 98 14.64 F 0.11323 IV N/D 
G4 Control 2N 87 13.07 F 0.33465 V N/D 
G5 Control 2N 107 20.07 F 0.12928 III N/D 
G6 Control 2N 92 14.72 F 0.10937 IV N/D 
G7 Control 2N 90 9.96 F 0.35953 V N/D 
G9 Control 2N 86 8.12 F 0.32718 V N/D 
G11 Control 2N 98 14.21 F 0.38227 V N/D 
G12 Control 2N 89 12.19 F 0.29681 V N/D 
G14 Control 2N 109 15.74 F 0.37385 V N/D 
G17 Control 2N 106 10.19 F 0.36699 V N/D 
G18 Control 2N 88 10.13 F 0.41301 V N/D 
G20 Control 2N 106 19.04 F 0.39990 V N/D 
G21 Control 2N 90 9.24 F 0.28640 V N/D 
G31 Low 2N 92 10.71 F 0.30022 V N/D 
G33 Low 2N 82 11.9 F 0.34735 V N/D 
G34 Low 2N 110 21.39 F 0.23715 V N/D 
G35 Low 2N 94 15.77 F 0.29933 V N/D 
G36 Low 2N 101 8.81 F 0.30970 V N/D 
G39 Low 2N 86 10.18 F 0.35773 V N/D 
G40 Low 2N 87 13.9 F 0.22772 IV N/D 
G41 Low 2N 98 13.35 F 0.27137 VI N/D 
G42 Low 2N 99 11.26 F 0.19801 VI N/D 
G43 Low 2N 89 10.22 F 0.31855 V N/D 
G44 Low 2N 108 16.73 F 0.19508 VI N/D 
G46 Low 2N 100 14.94 F 0.22100 V N/D 
G47 Low 2N 106 17.34 F 0.09540 VI N/D 
G48 Low 2N 97 13.8 F 0.27999 V N/D 
G51 Low 2N 103 14.59 F 0.41372 V N/D 
G52 Low 2N 99 12.32 F 0.16618 VI N/D 
H5 High 2N 82 14.3 I 0.05680 I N/D 
H6 High 2N 111 17.62 F 0.22214 V N/D 
H7 High 2N 98 15.6 F 0.25776 IV N/D 
H10 High 2N 107 18.8 F 0.18462 VI N/D 
H13 High 2N 82 7.33 F 0.20047 V N/D 
H14 High 2N 111 12.87 F 0.35232 V N/D 
H15 High 2N 95 8.16 F 0.38154 V N/D 
H16 High 2N 101 17.67 F 0.41616 V N/D 
H17 High 2N 90 6.02 F 0.10965 VI N/D 
H19 High 2N 96 13.09 F 0.28205 V N/D 
H27 High 2N 87 11.5 F 0.24366 V N/D 
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Table B.8 Unanalyzed data from initial evaluation of the experiment conducted in May 2004 
(Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
1 Initial 3N 110 23.05 F 0.08978 III 16.545 
2 Initial 3N 96 26.39 F 0.17188 III 20.563 
4 Initial 3N 99 15.64 F 0.04427 III 15.583 
5 Initial 3N 113 22.47 F 0.08318 III 19.542 
6 Initial 3N 107 18.18 F 0.04424 III 10.641 
9 Initial 3N 105 22.54 I 0.03009 I 12.928 
10 Initial 3N 126 30.5 F 0.09166 III 23.806 
12 Initial 3N 116 20.53 F 0.07954 III 26.193 
13 Initial 3N 88 13.7 F 0.08847 III 10.915 
14 Initial 3N 112 26.22 F 0.07544 III N/D 
15 Initial 3N 121 30 F 0.08470 III 14.692 
17 Initial 3N 95 16.24 F 0.11432 III 16849 
18 Initial 3N 112 17.1 F 0.16830 III 13.581 
20 Initial 3N 116 15.01 I N/D I 16.583 
1 Initial 2N 95 11.23 F 0.07548 III 11.911 
2 Initial 2N 83 12.96 F 0.18083 VI 12.091 
3 Initial 2N 89 14.64 F 0.21936 VI 12.091 
5 Initial 2N 103 14.66 F 0.16854 VI 18.783 
6 Initial 2N 91 16.12 F 0.35018 VI 22.523 
7 Initial 2N 94 11.4 I 0.03430 I   14.474 
8 Initial 2N 107 14.04 F 0.16397 VI 20.263 
10 Initial 2N 122 28.83 F 0.33311 VI 14.996 
11 Initial 2N 93 14.07 F 0.46815 V 25.495 
12 Initial 2N 99 18.44 F 0.12192 VI 13.448 
14 Initial 2N 100 13.66 F 0.30932 VI 12.815 
15 Initial 2N 111 25.34 F 0.38954 V 12.383 
16 Initial 2N 87 17.32 F N/D VI 13.838 
17 Initial 2N 101 15.48 F 0.32174 VI 14.277 
18 Initial 2N 99 14.5 F 0.37371 VI 13.567 
20 Initial 2N 104 12.38 F 0.19794 VI 19.338 
 
 
 
Table B.9 Unanalyzed data from triploid oysters evaluated at day 9 of experiment in May 2004 
(Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
F2 Control 3N 115 26.02 F 0.10123 III 27.715 
F4 Control 3N 106 28.98 F 0.15868 VI 14.824 
F6 Control 3N 118 22.64 F 0.06595 IV 16.104 
F8 Control 3N 99 18.81 F 0.06851 III 17.955 
F13 Control 3N 112 27.93 F N/D III 22.039 
F15 Control 3N 115 27.88 F 0.06132 III 16.821 
E46 Control 3N 108 29.8 F N/D III 42.461 
E47 Control 3N 101 19.04 F 0.17251 III 20.018 
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E49 Control 3N 119 24.76 F N/D III 45.755 
E50 Control 3N 99 21.22 F 0.06341 III 17.742 
E53 Control 3N 114 14.06 F N/D III 239.95 
E55 Control 3N 112 23.82 F N/D III 36.52 
E56 Control 3N 107 25.32 F 0.11236 III 18.475 
G1 Low 3N 124 27.92 F N/D IV N/D 
G5 Low 3N 106 19.43 F 0.06184 III N/D 
G8 Low 3N 113 20.75 F 0.05936 IV N/D 
G13 Low 3N 112 24.16 F 0.0805 III N/D 
F28 Low 3N 107 24.8 F N/D V N/D 
F29 Low 3N 116 29.13 F 0.04064 III N/D 
F31 Low 3N 104 21.23 F N/D III N/D 
F39 Low 3N 90 17.9 F 0.06398 III N/D 
F45 Low 3N 89 16.61 F 0.11785 III N/D 
F48 Low 3N 110 24.03 F 0.09405 III N/D 
F54 Low 3N 92 15.43 F 0.05627 III N/D 
A1 High 3N 109 15.7 F 0.09454 III N/D 
A2 High 3N 124 18.83 F 0.14409 III N/D 
A3 High 3N 131 26.27 F N/D III N/D 
A4 High 3N 108 12.16 I 0.07492 I N/D 
A5 High 3N 80 15.24 I N/D I N/D 
A6 High 3N 133 20.26 I 0.07056 I N/D 
A7 High 3N 118 24.29 I 0.02301 I N/D 
A9 High 3N 118 22.06 F 0.07625 III N/D 
A10 High 3N 109 18.54 I 0.03386 I N/D 
A11 High 3N 109 16.27 F 0.17431 III N/D 
A12 High 3N 96 21.84 F 0.13331 III N/D 
A13 High 3N 104 24.27 F 0.17371 III N/D 
A14 High 3N 122 27.01 F 0.09412 III N/D 
A16 High 3N 126 31.89 F 0.04926 III N/D 
H53 High 3N 137 31.5 F 0.09342 III N/D 
H56 High 3N 119 21.81 F N/D III N/D 
 
 
 
Table B.10 Unanalyzed data from triploid oysters evaluated at day 12 of experiment in May 
2004 (Chapter 4). 
 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
E1 Control 3N 121 26.66 I 0.02937 I 16.393 
E2 Control 3N 109 21.92 F 0.03764 III 21.059 
E6 Control 3N 116 29.29 F 0.05164 III 21.666 
E8 Control 3N 124 26.26 F 0.09268 III 16.746 
E9 Control 3N 114 28.88 F 0.08592 III 20.916 
E12 Control 3N 112 32.19 F 0.03472 III N/D 
E13 Control 3N 106 21.41 F 0.06495 III 12.243 
E14 Control 3N 89 14.99 F 0.14743 III 9.613 
E17 Control 3N 103 34.43 F 0.13202 III 25.413 
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Table B.11 Unanalyzed data from diploid oysters evaluated at day 9of the experiment in May 
2004 (Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
F3 Control 2N 83 15.83 F 0.2877 V 52.357 
F5 Control 2N 96 25.4 F N/D V 34.298 
F7 Control 2N 112 17.72 F N/D V 31.911 
F9 Control 2N 90 19.92 F 0.33549 V 15.779 
F10 Control 2N 98 18.52 F 0.44538 V 34.98 
F11 Control 2N 88 9.59 I 0.10089 I 13.095 
F16 Control 2N 103 27.38 F N/D V 30.612 
E18 Control 3N 101 16.11 I 0.12418 I 55.302 
E21 Control 3N 104 15.85 F 0.04671 III 23.225 
E29 Control 3N 115 20.17 F 0.05781 III 334.99 
E30 Control 3N 119 25.71 F N/D III 42.1 
E32 Control 3N 124 24.75 F 0.07695 III 31.076 
E37 Control 3N 132 21.44 F 0.05358 III 27.179 
G17 Low 3N 88 17.9 F 0.09762 III N/D 
G23 Low 3N 101 20.21 F 0.05784 III N/D 
G24 Low 3N 103 24.89 F 0.05319 III N/D 
G27 Low 3N 116 29.51 F 0.03014 III N/D 
G30 Low 3N 109 18.25 F 0.07427 III N/D 
G35 Low 3N 116 32.09 F N/D III N/D 
G44 Low 3N 120 14.75 I 0.11659 I N/D 
G47 Low 3N 108 19.92 F 0.07467 IV N/D 
G51 Low 3N 112 25.29 F 0.03733 III N/D 
G52 Low 3N 107 13.86 I 0.02786 I N/D 
G56 Low 3N 99 21.24 F 0.0538 III N/D 
H4 Low 3N 127 23.04 F 0.05881 III N/D 
H5 Low 3N 119 18.97 F 0.13023 III N/D 
H7 High 3N 112 30.51 F 0.13247 III N/D 
H8 High 3N 99 16.21 I 0.06798 I N/D 
H10 High 3N 111 18.93 F 0.07914 III N/D 
H14 High 3N 132 33.56 F 0.09855 III N/D 
H27 High 3N 118 24.1 F 0.14185 III N/D 
H30 High 3N 110 23.59 F 0.03442 III N/D 
H31 High 3N 111 29.63 F 0.07474 III N/D 
H32 High 3N 113 26.19 I 0.04411 I N/D 
H33 High 3N 123 26.16 I 0.14074 I N/D 
H34 High 3N 125 23.39 F 0.08594 III N/D 
H37 High 3N 113 14.49 F 0.08267 III N/D 
H39 High 3N 97 19.19 F 0.1094 III N/D 
H40 High 3N 93 15.64 I 0.03169 I N/D 
H42 High 3N 127 22.57 F 0.05594 III N/D 
H46 High 3N 117 23.15 F 0.08471 III N/D 
H48 High 3N 116 16.84 F N/D III N/D 
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F17 Control 2N 105 15.82 F 0.32097 V 15.711 
F20 Control 2N 93 13.62 F 0.0956 III 38.327 
F21 Control 2N 92 10.3 F 0.20845 VI 12.074 
E42 Control 2N 101 17.02 F N/D V 10.226 
E43 Control 2N 100 14.8 F N/D V 29.25 
E44 Control 2N 110 8.33 F 0.22065 VI 18.853 
E45 Control 2N 93 9.01 F 0.05633 VI 28.38 
E48 Control 2N 97 17.78 F 0.15015 VI 42.739 
G2 Low 2N 105 18.28 F 0.33425 IV N/D 
G3 Low 2N 83 19.9 F 0.27292 V N/D 
F30 Low 2N 87 14.18 F 0.22452 VI N/D 
F34 Low 2N 114 22.96 F 0.16636 V N/D 
F35 Low 2N 96 21.97 F 0.44507 V N/D 
F38 Low 2N 132 26.23 F 0.27485 V N/D 
F40 Low 2N 78 10.33 F 0.35748 V N/D 
F41 Low 2N 117 16.35 F 0.23768 V N/D 
F42 Low 2N 79 9.74 F 0.20966 VI N/D 
F43 Low 2N 83 14.95 F N/D V N/D 
F46 Low 2N 121 13.08 F 0.21149 VI N/D 
F47 Low 2N 102 18.15 F 0.07074 VI N/D 
F50 Low 2N 111 27.49 F N/D V N/D 
F51 Low 2N 104 24.56 F 0.20415 V N/D 
F55 Low 2N 108 21.58 F 0.36314 V N/D 
H18 High 2N 101 17.42 F N/D IV N/D 
H19 High 2N 111 14.24 F 0.1057 VI N/D 
H21 High 2N 104 16.17 F 0.29069 V N/D 
H22 High 2N 109 18.98 F N/D IV N/D 
H23 High 2N 103 22.13 F N/D IV N/D 
H24 High 2N 97 17.13 F N/D V N/D 
H25 High 2N 97 11.79 I 0.01873 I  N/D 
H28 High 2N 117 21.93 F N/D V N/D 
H29 High 2N 102 14.7 F 0.44201 V N/D 
H36 High 2N 103 23.97 F 0.30253 IV N/D 
H38 High 2N 92 18.84 F N/D V N/D 
H41 High 2N 98 16.61 F 0.32083 V N/D 
H44 High 2N 101 18.99 F 0.26995 V N/D 
H45 High 2N 109 18.88 F 0.22972 V N/D 
H47 High 2N 110 21.96 F N/D V N/D 
H50 High 2N 132 28.7 I N/D I N/D 
H51 High 2N 94 11.6 I 0.01411 I N/D 
H52 High 2N 100 14.74 F 0.27266 IV N/D 
H55 High 2N 102 15.16 F N/D IV N/D 
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Table B.12 Unanalyzed data from diploid oysters evaluated at day of the experiment 12 in May 
2004 (Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
E3 Control 2N 105 18.27 F 0.34239 V 12.843 
E4 Control 2N 97 17.01 F 0.36956 V 10.22 
E11 Control 2N 128 27.28 F 0.34171 V 33.931 
E15 Control 2N 102 20.26 F 0.28735 IV 17.147 
E19 Control 2N 107 25.21 I 0.05188 I N/D 
E22 Control 2N 98 15.65 F 0.25683 IV 22.44 
E23 Control 2N 124 14.08 F 0.3028 V 27.546 
E24 Control 2N 97 13.5 F 0.18852 IV 21.983 
E25 Control 2N 91 11.57 F 0.15115 IV 27.108 
E26 Control 2N 117 15.92 F N/D IV 116.08 
E28 Control 2N 107 20.79 F 0.24802 IV N/D 
E34 Control 2N 100 15.77 F 0.36502 V 16.535 
E35 Control 2N 107 11.92 F 0.40724 V 14.253 
E41 Control 2N 110 17.8 F 0.1864 III 11.483 
G4 Low 2N 99 32.32 F 0.32114 IV N/D 
G6 Low 2N 94 11.03 F 0.34401 V N/D 
G9 Low 2N 94 16.28 F 0.32671 V N/D 
G11 Low 2N 92 15.56 F 0.42736 V N/D 
G14 Low 2N 93 15.34 F 0.34474 V N/D 
G16 Low 2N 119 19.55 F 0.16655 III N/D 
G18 Low 2N 98 14.99 F 0.1144 VI N/D 
G22 Low 2N 106 15.75 F 0.3678 V N/D 
G28 Low 2N 104 17.43 F 0.25884 IV N/D 
G31 Low 2N 100 20.44 F 0.2111 IV N/D 
G33 Low 2N 112 15.44 F 0.10276 VI N/D 
G34 Low 2N 99 18.12 F 0.20063 VI N/D 
G36 Low 2N 89 15.56 F 0.25621 V  N/D 
G37 Low 2N 103 15.25 F 0.22036 IV N/D 
G38 High 2N 105 27.16 F 0.21499 V N/D 
G41 High 2N 114 17.76 F 0.49471 V N/D 
G42 High 2N 98 15.41 F 0.16387 VI N/D 
G45 High 2N 96 17.8 F N/D V N/D 
G46 High 2N 115 28.72 F 0.32069 V N/D 
G48 High 2N 94 13.21 F 0.13486 IV N/D 
G49 High 2N 110 19.4 F 0.24487 V N/D 
G50 High 2N 113 21.14 F 0.28083 V N/D 
G53 High 2N 110 11.79 I 0.07009 I N/D 
G55 High 2N 114 23.44 F N/D V N/D 
H1 High 2N 83 11.74 F 0.509 V N/D 
H3 High 2N 95 15.43 F 0.11435 IV N/D 
H6 High 2N 93 14.28 F 0.36474 V N/D 
H9 High 2N 91 9.83 F 0.53622 V N/D 
H11 High 2N 119 22.77 F 0.33129 V N/D 
H15 High 2N 114 15.29 F 0.30104 V N/D 
H17 High 2N 95 18.83 F 0.26525 IV N/D 
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Table B.13 Unanalyzed data from initial evaluation of the experiment conducted in August 2004 
(Chapter 4). 
 
 
 
Table B.14 Unanalyzed data from triploid oysters evaluated at day 12 of the experiment in 
August 2004 (Chapter 4). 
Oyster No Treatment Ploidy 
Shell 
height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
E5 Control 3N 121 24.98 F 0.06395 III N/D 
E6 Control 3N 130.5 24.32 F 0.037264 III 18.36 
E7 Control 3N 113.7 22.74 F 0.052301 III 69.45 
E8 Control 3N 94.5 16.07 F 0.099146 III 29.48 
E9 Control 3N 129 18.29 F 0.067914 III N/D 
E10 Control 3N 117.7 29.7 I 0.048612 I 28.21 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
1 Initial 3N 122.7 16.84 F 0.086746 III 29.82 
2 Initial 3N 105 27.12 F 0.075101 VI 41.39 
3 Initial 3N 113 13.45 F 0.084174 III 16.47 
5 Initial 3N 102.2 17.52 F 0.14683 III 17.86 
6 Initial 3N 106.6 16.81 F 0.068608 III 27.100 
7 Initial 3N 126.6 31.87 F 0.049154 IV 18.53 
8 Initial 3N 109.5 13.19 F 0.094739 IV 26.4 
10 Initial 3N 103.5 20.05 F 0.077739 III 39.96 
11 Initial 3N 86.5 14.25 F 0.055253 III 15.16 
13 Initial 3N 128.6 18.9 F 0.028676 III 21.14 
14 Initial 3N 92.9 8.89 F 0.09467 III 20.71 
15 Initial 3N 117.5 27.5 F 0.123435 IV 15.18 
18 Initial 3N 119.7 26.85 F 0.095893 IV 20.72 
19 Initial 3N 124.5 16.83 I 0.032854 I 18.83 
20 Initial 3N 120 14.77 F 0.191343 V 16.01 
1 Initial 2N 120 14.75 F 0.227953 V 16.07 
3 Initial 2N 98 11.28 F 0.357312 V 19.67 
5 Initial 2N 110 16.34 F 0.441621 V 19.44 
6 Initial 2N 107.2 12.02 F 0.415728 V 15.11 
7 Initial 2N 117.6 15.99 F 0.3328 V 14.25 
9 Initial 2N 100.7 16.38 F 0.27722 V 16.65 
11 Initial 2N 110.6 12.46 F 0.477376 V 17.5 
12 Initial 2N 106 11.74 F 0.458601 V N/D 
13 Initial 2N 112 23.1 F 0.320888 V 24.65 
14 Initial 2N 100.5 14.96 F 0.361932 V 35.12 
15 Initial 2N 108 18.11 F 0.258204 V 21.69 
16 Initial 2N 118.4 24.96 F N/D V 20.09 
17 Initial 2N 112.6 15.07 F 0.335911 V 24.68 
18 Initial 2N 121.2 10.92 F 0.44444 V 28.37 
19 Initial 2N 107.7 17.45 F 0.259858 V 20.04 
20 Initial 2N 102 15.93 F 0.396016 V 18.31 
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E11 Control 3N 99 22.66 F 0.077206 VI 33.8 
E13 Control 3N 112 10.11 F N/D III 48.83 
E16 Control 3N 93.1 9.77 F 0.185338 VI 16.12 
E19 Control 3N 117.8 12 F 0.164098 III 37.35 
E20 Control 3N 115 16.87 F 0.093255 III 14.3 
E21 Control 3N 86.8 12.98 F 0.037419 III 24.25 
E22 Control 3N 125.5 20.71 F 0.036581 III 24.72 
E24 Control 3N 84.1 16.95 F 0.060214 III 59.45 
E25 Control 3N 100 8.36 F 0.068182 III 36.850 
E26 Control 3N 108.9 10.87 F N/D III 71.73 
E27 Control 3N 106.1 18.06 F 0.046754 III 28.2 
E28 Control 3N 115.5 15.55 F 0.075844 III 19.51 
E29 Control 3N 119.2 17.29 F 0.144695 VI 20.58 
E30 Control 3N 97.5 22.07 F 0.107642 III 45.07 
E32 Control 3N 101.7 13.9 F 0.06904 VI 21.01 
E33 Control 3N 111.1 13.11 F 0.065715 III 21.23 
E34 Control 3N 95.9 7.82 F N/D III 32.94 
J1 Low 3N 118 21.65 F 0.036962 III N/D 
J2 Low 3N 98.5 14.59 F 0.096583 III N/D 
J3 Low 3N 95.5 12.62 F 0.117935 IV N/D 
J4 Low 3N 103.5 7.84 F 0.061248 III N/D 
J5 Low 3N 141 18.77 F 0.126032 III N/D 
J7 Low 3N 119 24.87 F 0.066809 III N/D 
J8 Low 3N 102 17.11 F 0.074359 III N/D 
J10 Low 3N 113 10.2 F 0.056488 III N/D 
J17 Low 3N 104.5 18.9 F 0.091346 III N/D 
J18 Low 3N 107.5 23.57 F 0.078295 VI N/D 
J19 Low 3N 141.2 23.08 I 0.104087 I N/D 
J21 Low 3N 106.1 12.31 F 0.063585 IV N/D 
J22 Low 3N 129.5 23.09 I 0.063456 I N/D 
J23 Low 3N 126.8 22.12 F 0.081452 III N/D 
J24 Low 3N 122 25.53 F 0.05376 III N/D 
J25 Low 3N 115 13.31 F 0.075784 III N/D 
J26 Low 3N 107.7 9.86 I 0.062612 I N/D 
J27 Low 3N 111.5 9.3 F 0.100166 III N/D 
J28 Low 3N 83.6 14.29 F 0.048376 III N/D 
J29 Low 3N 121.5 21.75 F 0.04036 III N/D 
J31 High 3N 110 22.03 F 0.05432 III N/D 
J33 High 3N 108 17.55 F N/D VI N/D 
J35 High 3N 123 20.38 F 0.057621 III N/D 
J36 High 3N 119 8.25 F 0.081416 III N/D 
J38 High 3N 86 15.87 F 0.067539 III N/D 
J39 High 3N 105 20.21 F 0.061191 III N/D 
J40 High 3N 98 11.1 F 0.116661 III N/D 
J41 High 3N 118 27.4 F N/D IV N/D 
J42 High 3N 150 36.62 I 0.020314 I N/D 
J43 High 3N 107 9.47 F 0.086941 III N/D 
J45 High 3N 122 14.08 F 0.240466 V N/D 
J46 High 3N 122 22.18 F 0.079261 III N/D 
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J47 High 3N 101 15.16 F 0.052754 III N/D 
J50 High 3N 122 21.5 F N/D IV N/D 
J53 High 3N 102 16.26 I 0.071697 I N/D 
J55 High 3N 96 12.56 F 0.103184 III N/D 
J56 High 3N 100 13.25 F 0.111294 III N/D 
E2 High 3N 125 19.88 F N/D V N/D 
E3 High 3N 116.8 22.41 F 0.266438 V N/D 
E4 High 3N 111 21.77 I 0.042325 I N/D 
 
 
 
Table B.15 Unanalyzed data from triploid oysters evaluated at day 15 of the experiment in 
August 2004 (Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
H31 Control 3N 96 18.2 F 0.045133 III 24.370 
H33 Control 3N 128.9 16.52 F 0.060829 III 16.840 
H35 Control 3N 112.5 14.89 F 0.085273 III 20.020 
H48 Control 3N 109.2 22.62 F 0.093778 III 44.690 
H49 Control 3N 101 14.06 F 0.20449 IV 46.040 
H50 Control 3N 114 22.09 F 0.062594 III 36.000 
H55 Control 3N 111 15.04 F 0.105282 III 25.880 
H2 Low 3N 104 17.22 F 0.053286 III N/D 
H4 Low 3N 115 24.46 F 0.055691 III N/D 
H5 Low 3N 101 19.38 F 0.121115 IV N/D 
H6 Low 3N 112 14.24 F 0.070049 III N/D 
H7 Low 3N 121 24.44 F 0.045375 III N/D 
H8 Low 3N 124 20.13 F 0.0889 III N/D 
H11 Low 3N 110 18.22 F 0.077361 III N/D 
H12 Low 3N 134.5 24013 F 0.110816 III N/D 
H15 Low 3N 108.7 19.19 F 0.091317 III N/D 
H17 Low 3N 106.4 14.52 F 0.088357 III N/D 
H18 Low 3N 121.8 25.2 F 0.047049 III N/D 
H19 Low 3N 100 15.78 F 0.062881 III N/D 
H20 Low 3N 91.5 11.25 F 0.06408 III N/D 
H23 Low 3N 99 9.71 F 0.086886 III N/D 
H24 Low 3N 109.2 15.48 F 0.057334 III N/D 
H25 Low 3N 102 11.64 F 0.069724 III N/D 
G1 High 3N 104 16.57 F 0.061026 III N/D 
G3 High 3N 100 16.45 F 0.201841 V N/D 
G4 High 3N 97 11.93 F N/D V N/D 
G5 High 3N 106 14.05 I 0.073855 I N/D 
G6 High 3N 92 18.54 F N/D V N/D 
G10 High 3N 94.8 10.05 F 0.439279 V N/D 
G11 High 3N 121 17.85 F 0.285424 V N/D 
G15 High 3N 130 16.24 F 0.037271 III N/D 
G17 High 3N 101 16.27 F 0.100146 III N/D 
G20 High 3N 136.2 18.06 F 0.076021 III N/D 
G21 High 3N 117 14.82 F 0.126868 V N/D 
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G22 High 3N 118 19.52 F 0.055653 III N/D 
G23 High 3N 140 25.29 F 0.038392 III N/D 
G24 High 3N 132 24.76 F 0.032131 III N/D 
G25 High 3N 100 16.28 F 0.058425 III N/D 
 
 
 
Table B.16 Unanalyzed data from diploid oysters evaluated at day 12 of the experiment in 
August 2004 (Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
I2 Control 2N 115 19.84 F 0.213272 IV 57.25 
I3 Control 2N 108 11.88 F 0.228321 V 25.12 
I4 Control 2N 142 15.51 F 0.071301 VI 22.36 
I5 Control 2N 122 19.02 F 0.180984 V 25.08 
I8 Control 2N 143 17.19 F N/D V 23.43 
I10 Control 2N 99 11.45 F N/D VI 46.42 
I11 Control 2N 111.9 13.97 F N/D VI 25.7 
I13 Control 2N 99 13.34 F 0.237695 V 27.15 
I16 Control 2N 121 22.23 F 0.213281 V 26.74 
I17 Control 2N 116 17.13 F 0.212259 V 36.65 
I20 Control 2N 100 9.38 F 0.133306 VI 46.45 
I21 Control 2N 104 10.37 F 0.236582 V 12.71 
I33 Low 2N 105 15.38 F 0.234348 V N/D 
I34 Low 2N 116 21.18 F 0.218829 V N/D 
I35 Low 2N 98 10.87 F 0.181063 IV N/D 
I36 Low 2N 87 7.09 F N/D V N/D 
I37 Low 2N 99 9.89 F 0.205092 V N/D 
I38 Low 2N 112 15.28 F 0.204213 V N/D 
I39 Low 2N 94 12.4 F 0.216402 V N/D 
I40 Low 2N 110 16.62 F 0.181135 V N/D 
C1 Low 2N 134 12.28 F 0.134883 V N/D 
C4 Low 2N 144 16.97 F 0.184481 IV N/D 
C5 Low 2N 115.8 12.31 F 0.262574 V N/D 
C6 Low 2N 93 10.03 F 0.283097 V N/D 
C7 Low 2N 105.8 13.89 F 0.140386 IV N/D 
C8 Low 2N 111 11.05 F 0.302075 V N/D 
C9 Low 2N 104 11.27 F 0.273326 V N/D 
I41 High 2N 124 14.53 F 0.168677 V N/D 
I42 High 2N 97 9.91 F N/D V N/D 
I44 High 2N 110 11.93 F N/D V N/D 
I47 High 2N 105 17.46 F 0.303985 IV N/D 
I49 High 2N 92 13.31 F N/D V N/D 
I50 High 2N 111 12.76 F 0.166264 V N/D 
C21 High 2N 105 11.78 F 0.134439 IV N/D 
C25 High 2N 124 13.28 F 0.150976 IV N/D 
C26 High 2N 139 16.85 F 0.296482 V N/D 
C28 High 2N 104 12.46 F 0.167395 V N/D 
C29 High 2N 92 10.36 F 0.190676 V N/D 
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C30 High 2N 111 14.34 F 0.300796 V N/D 
C31 High 2N 125 19.8 F 0.234926 IV N/D 
C35 High 2N 101 10.49 F 0.255348 V N/D 
C38  High 2N 122 18.17 F 0.181387 V N/D 
 
 
 
Table B.17 Unanalyzed data from diploid oysters evaluated at day 15 in August 2004     
(Chapter 4). 
Oyster No Treatment Ploidy Shell height Weight Sex GBR Gonad  Estradiol 
       (mm) (g)     Stage (pg/ml) 
G28 Control 2N 99 9.83 F N/D VI 16.090 
G29 Control 2N 123 20.54 F 0.336573 V 21.390 
G30 Control 2N 122 21.97 F N/D V 23.750 
G31 Control 2N 129 16.16 F 0.164247 V 41.900 
G32 Control 2N 117 19.67 F 0.260167 V 126.300 
G35 Control 2N 111 23.39 F 0.334527 V 20.290 
G36 Control 2N 108 29.34 F 0.236516 V 40.520 
G37 Control 2N 102 11.43 F 0.387955 V 16.710 
G38 Control 2N 91.8 9.99 F N/D V 21.620 
G39 Control 2N 117 15.48 F 0.252258 V 23.690 
G43 Control 2N 113 22.07 F 0.441348 V 41.840 
G44 Control 2N 105 16.5 F 0.367044 V 16.660 
G46 Control 2N 114 18.13 F 0.252189 V 31.920 
B11 Low 2N 111.7 24.99 F 0.261757 V N/D 
B14 Low 2N 119 19.46 F 0.288667 V N/D 
B15 Low 2N 113 10.76 F 0.399239 V N/D 
B18 Low 2N 110 16.49 F 0.298472 V N/D 
B19 Low 2N 115 20 F 0.327758 V N/D 
B20 Low 2N 112 20.15 F 0.217094 V N/D 
B21 Low 2N 116 19.16 F 0.221758 V N/D 
B22 Low 2N 117 17.4 F 0.285447 V N/D 
B23 Low 2N 122 17.49 F 0.202661 V N/D 
B24 Low 2N 110 20.43 F 0.338644 V N/D 
B25 Low 2N 104 21.1 F 0.250921 V N/D 
B27 Low 2N 108.7 24.53 F 0.298905 V N/D 
B28 Low 2N 123 17.76 F 0.257946 V N/D 
D12 High 2N 100 16.76 F 0.199923 V N/D 
D14 High 2N 121 25.99 F 0.286505 V N/D 
D15 High 2N 125 19.05 F 0.259994 V N/D 
D17 High 2N 93.5 15.82 F 0.160245 V N/D 
D18 High 2N 150 24.78 F 0.298345 V N/D 
D20 High 2N 107 10.72 F 0.18361 V N/D 
D21 High 2N 107 14.81 F 0.27197 V N/D 
D22 High 2N 98 16.71 F 0.200349 V N/D 
D24 High 2N 121 23.61 F 0.179151 V N/D 
D25 High 2N 133 15.13 F N/D V N/D 
D26 High 2N 94 13.88 F 0.257419 V N/D 
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Table B.18 Unanalyzed data of oocyte area from diploid oysters evaluated in August 2003 and 
May and August 2004 (Chapter 4). 
Oyster No Experiment Treatment Oocyte Area (µm) 
A2 August 2003 Control 1072.08 
A13 August 2003 Control 1006.22 
A19 August 2003 Control 916.60 
A29 August 2003 Control 948.83 
A38 August 2003 Control 953.79 
B3 August 2003 Control 931.31 
B15 August 2003 Control 997.45 
B18 August 2003 Control 827.43 
B31 August 2003 Control 878.98 
A12 August 2003 Control 930.15 
A14 August 2003 Control 950.79 
A23 August 2003 Control 1047.55 
A31 August 2003 Control 864.89 
B1 August 2003 Control 873.57 
B6 August 2003 Control 925.98 
B17 August 2003 Control 934.57 
B25 August 2003 Control 1058.58 
D17 August 2003 Low 974.27 
B32 August 2003 Low 1070.77 
B33 August 2003 Low 989.81 
B39 August 2003 Low 912.94 
C10 August 2003 Low 1014.89 
C35 August 2003 Low 1055.82 
D16 August 2003 Low 869.93 
D19 August 2003 Low 1111.32 
B37 August 2003 Low 840.76 
C6 August 2003 Low 963.56 
C34 August 2003 Low 912.44 
D17 August 2003 Low 889.69 
D4 August 2003 Low 947.37 
E4 August 2003 High 1116.42 
E10 August 2003 High 1117.75 
E23 August 2003 High 1068.58 
E34 August 2003 High 967.35 
D26 August 2003 High 833.12 
E1 August 2003 High 1033.54 
E9 August 2003 High 1147.11 
E11 August 2003 High 973.42 
E33 August 2003 High 997.20 
D23 August 2003 High 995.47 
D34 August 2003 High 1028.75 
E42 May 2004 (day 9) Control 802.38 
E44 May 2004 (day 9) Control 869.90 
F5 May 2004 (day 9) Control 923.08 
F9 May 2004 (day 9) Control 822.36 
F16 May 2004 (day 9) Control 766.95 
F20 May 2004 (day 9) Control 706.86 
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Table B.18 continued 
E43 May 2004 (day 9) Control 968.96 
F3 May 2004 (day 9) Control 870.48 
F7 May 2004 (day 9) Control 876.72 
F10 May 2004 (day 9) Control 821.84 
F17 May 2004 (day 9) Control 815.28 
F21 May 2004 (day 9) Control 602.79 
F30 May 2004 (day 9) Low 702.01 
F35 May 2004 (day 9) Low 629.49 
F40 May 2004 (day 9) Low 681.90 
F42 May 2004 (day 9) Low 679.04 
F46 May 2004 (day 9) Low 595.42 
F50 May 2004 (day 9) Low 603.48 
F55 May 2004 (day 9) Low 745.93 
G3 May 2004 (day 9) Low 688.76 
F34 May 2004 (day 9) Low 644.00 
F38 May 2004 (day 9) Low 675.18 
F41 May 2004 (day 9) Low 642.06 
F43 May 2004 (day 9) Low 607.95 
F47 May 2004 (day 9) Low 646.01 
F51 May 2004 (day 9) Low 736.97 
G2 May 2004 (day 9) Low 777.20 
H18 May 2004 (day 9) High 760.85 
H21 May 2004 (day 9) High 706.07 
H23 May 2004 (day 9) High 641.43 
H28 May 2004 (day 9) High 597.30 
H36 May 2004 (day 9) High 790.77 
H41 May 2004 (day 9) High 708.05 
H52 May 2004 (day 9) High 682.37 
H19 May 2004 (day 9) High 792.58 
H22 May 2004 (day 9) High 607.97 
H24 May 2004 (day 9) High 596.06 
H29 May 2004 (day 9) High 639.93 
H38 May 2004 (day 9) High 673.01 
H47 May 2004 (day 9) High 686.67 
H55 May 2004 (day 9) High 711.88 
E3 May 2004 (day12) Control 645.62 
E11 May 2004 (day12) Control 649.75 
E22 May 2004 (day12) Control 706.68 
E25 May 2004 (day12) Control 747.90 
E28 May 2004 (day12) Control 775.92 
E35 May 2004 (day12) Control 765.67 
E4 May 2004 (day12) Control 684.22 
E15 May 2004 (day12) Control 716.48 
E23 May 2004 (day12) Control 726.13 
E26 May 2004 (day12) Control 792.38 
E34 May 2004 (day12) Control 663.44 
E41 May 2004 (day12) Control 468.02 
G4 May 2004 (day12) Low 795.46 
G9 May 2004 (day12) Low 766.96 
G14 May 2004 (day12) Low 787.21 
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Table B.18 Continued 
G22 May 2004 (day12) Low 807.96 
G31 May 2004 (day12) Low 723.44 
G36 May 2004 (day12) Low 737.07 
G6 May 2004 (day12) Low 867.78 
G11 May 2004 (day12) Low 835.86 
G16 May 2004 (day12) Low 819.58 
G28 May 2004 (day12) Low 797.94 
G34 May 2004 (day12) Low 780.33 
G37 May 2004 (day12) Low 786.34 
G38 May 2004 (day12) High 671.05 
G42 May 2004 (day12) High 756.95 
G46 May 2004 (day12) High 750.15 
G50 May 2004 (day12) High 752.93 
H1 May 2004 (day12) High 812.76 
H6 May 2004 (day12) High 717.78 
H11 May 2004 (day12) High 646.50 
H17 May 2004 (day12) High 748.23 
G41 May 2004 (day12) High 712.95 
G45 May 2004 (day12) High 802.80 
G49 May 2004 (day12) High 736.68 
G55 May 2004 (day12) High 683.64 
H3 May 2004 (day12) High 765.03 
H9 May 2004 (day12) High 831.16 
H15 May 2004 (day12) High 740.62 
I3 August2004 (day12) Control 622.72 
I13 August2004 (day12) Control 654.99 
I17 August2004 (day12) Control 658.69 
I5 August2004 (day12) Control 773.28 
I6 August2004 (day12) Control 685.19 
I21 August2004 (day12) Control 683.84 
C1 August2004 (day12) Low 596.96 
I33 August2004 (day12) Low 674.36 
I36 August2004 (day12) Low 689.22 
I38 August2004 (day12) Low 647.43 
I40 August2004 (day12) Low 558.98 
C5 August2004 (day12) Low 692.55 
I34 August2004 (day12) Low 616.43 
I37 August2004 (day12) Low 691.54 
I39 August2004 (day12) Low 686.37 
C26 August2004 (day12) High 634.03 
C30 August2004 (day12) High 712.05 
I41 August2004 (day12) High 620.77 
I44 August2004 (day12) High 659.45 
C28 August2004 (day12) High 704.06 
C35 August2004 (day12) High 684.22 
I42 August2004 (day12) High 648.60 
I49 August2004 (day12) High 605.23 
G29 August2004 (day15) Control 646.62 
G31 August2004 (day15) Control 672.59 
G35 August2004 (day15) Control 621.72 
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Table B.18 Continued 
G37 August2004 (day15) Control 661.23 
G39 August2004 (day15) Control 712.80 
G44 August2004 (day15) Control 680.05 
G30 August2004 (day15) Control 621.69 
G32 August2004 (day15) Control 651.52 
G36 August2004 (day15) Control 590.00 
G38 August2004 (day15) Control 729.59 
G43 August2004 (day15) Control 584.05 
G46 August2004 (day15) Control 603.46 
B11 August2004 (day15) Low 621.06 
B15 August2004 (day15) Low 613.89 
B19 August2004 (day15) Low 746.35 
B21 August2004 (day15) Low 676.97 
B23 August2004 (day15) Low 623.14 
B25 August2004 (day15) Low 649.58 
B28 August2004 (day15) Low 587.68 
B14 August2004 (day15) Low 732.88 
B18 August2004 (day15) Low 663.31 
B20 August2004 (day15) Low 656.50 
B22 August2004 (day15) Low 646.95 
B24 August2004 (day15) Low 626.61 
B27 August2004 (day15) Low 717.39 
C9 August2004 (day15) Low 708.27 
D12 August2004 (day15) High 632.00 
D15 August2004 (day15) High 616.33 
D20 August2004 (day15) High 673.62 
D22 August2004 (day15) High 720.72 
D26 August2004 (day15) High 618.34 
D30 August2004 (day15) High 681.90 
D14 August2004 (day15) High 613.28 
D18 August2004 (day15) High 758.95 
D21 August2004 (day15) High 663.03 
D25 August2004 (day15) High 626.79 
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